<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Neurol</journal-id>
      <journal-title>Journal of Neurology</journal-title>
      <issn pub-type="ppub">0340-5354</issn>
      <issn pub-type="epub">1432-1459</issn>
      <publisher>
        <publisher-name>Steinkopff-Verlag</publisher-name>
        <publisher-loc>Darmstadt</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17318714</article-id>
      <article-id pub-id-type="pmc">1915650</article-id>
      <article-id pub-id-type="publisher-id">296</article-id>
      <article-id pub-id-type="doi">10.1007/s00415-006-0296-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tremor in multiple sclerosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Koch</surname>
            <given-names>Marcus</given-names>
          </name>
          <degrees>MD</degrees>
          <address>
            <phone>+ 31-50-36/11-2430</phone>
            <fax>+ 31-50-36/11-707</fax>
            <email>m.w.koch@neuro.umcg.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mostert</surname>
            <given-names>Jop</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Heersema</surname>
            <given-names>Dorothea</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Keyser</surname>
            <given-names>Jacques</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Dept. of Neurology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>2</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2007</year>
      </pub-date>
      <volume>254</volume>
      <issue>2</issue>
      <fpage>133</fpage>
      <lpage>145</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>11</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>5</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Steinkopff Verlag Darmstadt 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>Tremor is estimated to occur in about 25 to 60 percent of patients with multiple sclerosis (MS). This symptom, which can be severely disabling and embarrassing for patients, is difficult to manage. Isoniazid in high doses, carbamazepine, propranolol and gluthetimide have been reported to provide some relief, but published evidence of effectiveness is very limited. Most trials were of small size and of short duration. Cannabinoids appear ineffective. Tremor reduction can be obtained with stereotactic thalamotomy or thalamic stimulation. However, the studies were small and information on long-term functional outcome is scarce. Physiotherapy, tremor reducing orthoses, and limb cooling can achieve some functional improvement. Tremor in MS remains a significant challenge and unmet need, requiring further basic and clinical research.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>multiple sclerosis</kwd>
        <kwd>treatment</kwd>
        <kwd>tremor</kwd>
        <kwd>ataxia</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Steinkopff Verlag Darmstadt 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Search strategy and selection criteria</title>
      <p>References for this review were identified from searches of Pubmed (from 1966 to 2005) and the Cochrane Library (2005, Issue 2) with the search terms &#x201C;multiple sclerosis&#x201D;, &#x201C;tremor&#x201D;, &#x201C;ataxia&#x201D;, &#x201C;disability&#x201D;, &#x201C;prevalence&#x201D;, &#x201C;surgery&#x201D;, &#x201C;thalamotomy&#x201D;, &#x201C;deep brain stimulation&#x201D; and &#x201C;treatment&#x201D;. Articles were also identified through searches of the reference tables of identified papers. Furthermore we searched the ISI Science Citation Index for relevant articles citing identified papers. Only articles in English and German were included in the review; publications in abstract form were not considered.</p>
    </sec>
    <sec id="Sec2" sec-type="introduction">
      <title>Introduction</title>
      <p>Tremor is such a common problem in multiple sclerosis (MS) that the famous French neurologist Charcot (1825&#x2013;1893) described it as a part of his triad of characteristic symptoms in MS, together with nystagmus, and scanning speech.</p>
      <p>Tremor of the upper limbs can be very disabling and seriously impair many activities of daily living and quality of life. In practice the treatment of tremor in MS is often frustrating. In this review we discuss medical, surgical and other treatment options.</p>
      <sec id="Sec3">
        <title>Epidemiology</title>
        <p>Although the epidemiology of symptoms in MS has been studied extensively, it remains difficult to ascertain the prevalence of tremor in historic study populations, mostly because Kurtzke&#x2019;s functional systems scale for cerebellar function, which is most widely used in clinical studies in MS, does not record tremor [<xref ref-type="bibr" rid="CR55">55</xref>]. In a large long-term follow-up study, Weinshenker and colleagues found functionally relevant cerebellar deficits in one third of 259 patients [<xref ref-type="bibr" rid="CR94">94</xref>]. In another study, disability and dependency of patients with MS were shown to correlate with the severity of ataxia [<xref ref-type="bibr" rid="CR95">95</xref>].</p>
        <p>Two newer studies assessed the prevalence of tremor in MS. One study by Alusi and coworkers examined 100 patients randomly selected from a London MS-clinic and found tremor in 58% of patients. The tremor was minimal in 27%, mild in 16% and moderate to severe in 15% of all patients [<xref ref-type="bibr" rid="CR6">6</xref>]. As patients were selected from a specialist clinic, the relatively high prevalence and severity of tremor might be due to selection bias.</p>
        <p>In a prevalence cohort study by Pittock and colleagues, 200 MS patients living in Olmsted County, Minnesota, USA were assessed for tremor and measures of disability. Tremor was found in 25.5% and severe tremor in 3% of the study population [<xref ref-type="bibr" rid="CR74">74</xref>]. Probably the community based population in the latter study gives a more realistic estimate of tremor prevalence in MS. In both studies, however, tremor was associated with greater disability as measured on the expanded disability status scale (EDSS). In the Olmsted County population, patients with tremor of any severity were more likely to be unemployed or retired early because of disability.</p>
      </sec>
      <sec id="Sec4">
        <title>Tremor subtypes</title>
        <p>Tremor in MS can involve the head, neck, vocal cords, trunk and limbs, whereas involvement of the tongue, jaw or palate has not been reported [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
        <p>The different types of tremor are currently classified according to a working consensus of the Movement Disorder Society [<xref ref-type="bibr" rid="CR29">29</xref>]. In MS, the two most prevalent tremor forms are postural tremor (tremor present whilst voluntarily maintaining a position against gravity) and intention tremor (tremor occurring during target directed movement where tremor amplitude increases during visually guided movements towards the target). True rest tremor (tremor present in a body part that is not voluntarily activated and is completely supported against gravity) is unusual in patients with MS, and Holmes (or &#x201C;rubral&#x201D;) tremor is also very uncommon.</p>
        <p>In the two main prevalence studies, [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR74">74</xref>] rest tremor was observed only in the Olmsted County survey (1% of patients), whereas Holmes tremor was observed in neither study. An overview of the affected body parts observed in both studies is given in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. In both studies tremor was most commonly found in the arms. In the London study population, 36% of patients suffered from bilateral arm tremor, making this the most common pattern of limb involvement.
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Details of the two main prevalence studies on tremor in MS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">London [<xref ref-type="bibr" rid="CR6">6</xref>] (n&#xA0;=&#xA0;100)</th><th align="left">Olmsted County [<xref ref-type="bibr" rid="CR74">74</xref>] (n&#xA0;=&#xA0;200)</th></tr></thead><tbody><tr><td align="left">Total patients with tremor</td><td char=" " align="char">58 (58%)</td><td char=" " align="char">51 (25.5%)</td></tr><tr><td align="left">Patients with severe tremor</td><td char=" " align="char">15 (15%)</td><td char=" " align="char">6 (3%)</td></tr><tr><td align="left">Arm tremor</td><td char=" " align="char">56 (56%)</td><td char=" " align="char">47 (23.5%)</td></tr><tr><td align="left">Bilateral arm tremor</td><td char=" " align="char">36 (36%)</td><td char=" " align="char">not reported</td></tr><tr><td align="left">Leg tremor</td><td char=" " align="char">10 (10%)</td><td char=" " align="char">12 (6%)</td></tr><tr><td align="left">Head tremor</td><td char=" " align="char">9 (9%)</td><td char=" " align="char">7 (3.5%)</td></tr><tr><td align="left">trunk tremor</td><td char=" " align="char">7 (7%)</td><td char=" " align="char">not reported</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Pathophysiology of tremor</title>
        <p>The pathophysiology of tremor in MS is a difficult area of investigation, partly because MS is by definition a multifocal disease, so that tremor occurrence cannot easily be linked to a single neuroanatomical site. Systematic postmortem studies on the link between lesion site and the clinical phenomenon of tremor have never been undertaken.</p>
        <p>The predominance of action tremors (postural and intention) in patients with MS point to the cerebellum and its connections as the most likely source of tremor production, whereas the rarity of rest tremor argues against an involvement of the basal ganglia. The common occurrence of bilateral tremor might indicate that damage to the cerebellum and its connections is often multifocal.</p>
        <p>Another link to the cerebellum in the pathophysiology of tremor in MS is the effect of peripheral cooling on intention tremor. Intention tremor is thought to be modulated through increased long latency stretch reflexes [<xref ref-type="bibr" rid="CR30">30</xref>]. Cooling has been shown to decrease the sensitivity of muscle spindles [<xref ref-type="bibr" rid="CR64">64</xref>] and the velocity of peripheral nerve conduction [<xref ref-type="bibr" rid="CR56">56</xref>]. In two experimental studies, cooling of the arms markedly reduced intention tremor severity in patients with MS [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. The authors argue that this effect might have been partly due to decreased muscle spindle function and decreased nerve conduction velocity, which in turn resulted in decreased input into tremor producing cerebellar circuits.</p>
        <p>Alusi and coworkers drew attention to the placement site of deep brain stimulation (DBS) electrodes to help understand the neuronal circuits involved in tremor production. They stated that neurosurgeons increasingly chose the nucleus ventralis oralis posterior (VOP) of the thalamus rather than the classic target, the nucleus ventralis intermedius (VIM). This is interesting because the VOP is the basal ganglia output nucleus of the thalamus [<xref ref-type="bibr" rid="CR6">6</xref>], suggesting that the cerebellar tremors seen in MS might actually be generated by the basal ganglia. The standard electrode placement site reported in the literature, however, is the VIM and no studies comparing placement sites have been published. Whittle and coworkers comment on the difficulty of electrode placement in MS patients: in most patients there are major brain distortions due to demyelination, plaque formation and e vacuo hydrocephalus, and it is therefore uncertain whether the anatomy of these patients conforms to standard stereotactic atlasses [<xref ref-type="bibr" rid="CR100">100</xref>]. Keeping these comments in mind, it seems unwise to base pathophysiological theories purely on DBS electrode placement site.</p>
        <p>A range of animal experiments have been undertaken to indentify the anatomical structures involved in tremor production (for review [<xref ref-type="bibr" rid="CR101">101</xref>]). It has been shown that damage or removal of the cerebellar cortex does not induce intention tremor in monkeys, [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR76">76</xref>] whereas partial or complete cerebellectomy leads to tremor during movement and posture [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. A slow, 3&#x2013;5 Hz tremor during target directed movements can also be induced by reversible cooling of the dentate nucleus (the origin of most cerebellar efferents) in monkeys [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
        <p>Most cerebellar efferents project from the dentate nucleus via the superior cerebellar peduncle (brachium conjunctivum) to the red nucleus and the thalamus. According to some studies, transection of the superior cerebellar peduncle causes intention tremor in monkeys [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR93">93</xref>], whereas other authors do not mention this effect.</p>
        <p>Interestingly, Carpenter and colleagues report that tremor induced by transection of the superior cerebellar peduncle can be alleviated by a second lesion in the lateroventral or centromedian thalamus. [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] The results of these animal studies suggest that damage to cerebellar efferents (through lesions of the dentate nucleus or superior cerebellar peduncle) may cause disinhibition of thalamic nuclei which are the main producers of intention tremor.</p>
        <p>Although this is an interesting pathophysiologic model of intention tremor production, it remains uncertain whether the results of animal studies can be generalized to patients with MS.</p>
        <p>In summary, clinical observation, animal studies and some experimental evidence in humans favour the cerebellum and the thalamic nuclei connected to it as the major locus of intention tremor production, but more research is needed to evaluate the role of the basal ganglia and other systems in tremor production in MS.</p>
      </sec>
      <sec id="Sec6">
        <title>Assessment of tremor</title>
        <p>Depending on the subtype of tremor, several methods for the assessment of tremor severity and its impact on the lives of patients have been developed. Rest tremor is often assessed with the tremor subscale of the Unified Parkinson&#x2019;s Disease Rating Scale (UPDRS). Fahn and colleagues devised the most comprehensive tremor scale for non-parkinsonian tremor in 1984 [<xref ref-type="bibr" rid="CR33">33</xref>]. This instrument measures tremor in nine body parts at rest, while maintaining a posture and during goal directed movements. It also includes an assessment of arm tremor while writing and pouring water as well as a subscale for functional disability (interference of tremor with dressing, writing, eating etc.). Some studies included in this review use a modified and heavily abbreviated version of this scale, but most studies assess tremor by clinical examination only (e.g. by finger-to-nose testing, drinking from a cup, nine-hole-peg-test or writing and drawing tasks) or use a simple ordinal severity scale, often classifying tremor as absent, mild, moderate or severe. A simple 0&#x2013;10 tremor severity scale devised by Bain and coworkers [<xref ref-type="bibr" rid="CR11">11</xref>] has been shown to be a valid and reliable measurement tool in patients with MS [<xref ref-type="bibr" rid="CR7">7</xref>], but has so far only been used in few clinical studies [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p>
        <p>Accelerometry and polarized light goniometry are neurophysiologic methods of tremor assessment. While these methods offer an objective measurement of tremor severity, they can only measure one aspect of an often complex movement problem at a time, and e.g. cannot measure the ataxia which often complicates tremor in MS.</p>
        <p>Matsumoto and colleagues devised a more complex &#x201C;quantitative movement analysis technique&#x201D;, which records the patients&#x2019; goal directed movements in three dimensions using an electromagnetic tracking device, but the complexity of this method [<xref ref-type="bibr" rid="CR62">62</xref>] as well as the computer aided tracking tasks employed by Aisen and coworkers [<xref ref-type="bibr" rid="CR2">2</xref>] prohibit their widespread use.</p>
        <p>One of the most important aspects of tremor in MS is its impact on the daily life of the patients. Functional status in MS-patients is often measured by asking the patients to complete questionnaires assessing activities of daily living such as writing, eating or dressing. Often these scales are self-devised and not validated. Validated scales used in the studies reviewed in this article include the Frenchay Activities Index [<xref ref-type="bibr" rid="CR85">85</xref>] and the quality of life subscale of the Functional Assessment of Multiple Sclerosis Scale (FAMS) [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
      </sec>
      <sec id="Sec7">
        <title>Medical treatment</title>
        <p>A summary of the published studies on medical treatment of tremor in MS is given in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>. Most of the published literature on medical treatment consists of case reports and uncontrolled open label studies. The few randomized controlled trials comprised small numbers of patients and very likely lacked the power to reveal small treatment effects.
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Studies on medical treatment of tremor in MS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="left">n*</th><th align="left">study design</th><th align="left">intervention(s)</th><th align="left">tremor assessment</th><th align="left">patients with tremor reduction (%)</th><th align="left">patients with improved functional status (%)</th><th align="left">adverse effects (n)</th></tr></thead><tbody><tr><td align="left">Koller, 1984 [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td align="left">3</td><td align="left">double-blind placebo-controlled crossover</td><td align="left">propranolol (not specified) isoniazid (po.) 1200mg/d ethanol (iv.) 50ml of 10% solution</td><td align="left">writing tasks, patient self assessment, clinical examination, accelerometry</td><td align="left" colspan="2">no effect</td><td align="left">hepatitis while on isoniazid treatment (1)</td></tr><tr><td align="left">Sabra et al. 1982 [<xref ref-type="bibr" rid="CR80">80</xref>]</td><td align="left">4</td><td align="left">case reports</td><td align="left">isoniazid (po.) 400 to 1200mg/d</td><td align="left">clinical examination</td><td align="left">4 (100%)</td><td align="left">4 (100%)</td><td align="left">abnormal liver function tests (1)</td></tr><tr><td align="left">Duquette et al. 1985 [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td align="left">12</td><td align="left">open label</td><td align="left">isoniazid (po.) 500&#x2013;1000mg/d</td><td align="left">patient self assessment, clinical examination, blinded evaluation of video tapes</td><td align="left">10 (83%)</td><td align="left">0</td><td align="left">drowsiness, dysphagia, increased bronchial secretions (6) abnormal liver function tests (2) fatigue (2)</td></tr><tr><td align="left">Morrow et al. 1985 [<xref ref-type="bibr" rid="CR67">67</xref>]</td><td align="left">5</td><td align="left">open label</td><td align="left">isoniazid (po.) 700&#x2013;1200 mg/d</td><td align="left">clinical examination</td><td align="left">4 (80%)</td><td align="left">4 (80%)</td><td align="left">increased weakness (2) drowsiness (1)</td></tr><tr><td align="left">Francis et al. 1986 [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td align="left">5</td><td align="left">open label</td><td align="left">isoniazid (po.) 1200 mg/d</td><td align="left">clinical examination, polarised light goniometry</td><td align="left">4 (80%)</td><td align="left">0</td><td align="left">anorexia and nausea (3)</td></tr><tr><td align="left">Hallet et al. 1985 [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td align="left">6</td><td align="left">double-blind placebo-controlled crossover</td><td align="left">isoniazid (po.) 1200 mg/d</td><td align="left">self-rating scales, accelerometry, blinded evaluation of video tapes</td><td align="left">6 (100%)</td><td align="left">0</td><td align="left">None</td></tr><tr><td align="left">Bozek et al. 1987 [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td align="left">8</td><td align="left">double-blind placebo-controlled crossover</td><td align="left">isoniazid (po.) 12 or 20 mg/kg</td><td align="left">clinical examination, accelerometry, blinded evaluation of video tapes</td><td align="left">6 (75%)</td><td align="left">4 (50%)</td><td align="left">somnolence (3) **</td></tr><tr><td align="left">Sechi et al. 1989 [<xref ref-type="bibr" rid="CR86">86</xref>]</td><td align="left">7</td><td align="left">single-blind placebo controlled</td><td align="left">carbamazepine (po.) 400 or 600 mg/d</td><td align="left">clinical tremor rating scale, accelerometry</td><td align="left">7 (100%)</td><td align="left">not reported</td><td align="left">none reported</td></tr><tr><td align="left">Rice et al. 1997 [<xref ref-type="bibr" rid="CR78">78</xref>]</td><td align="left">16</td><td align="left">double-blind placebo-controlled crossover</td><td align="left">ondansetron (iv.) 8 mg (single dose)</td><td align="left">nine-hole peg-test, writing tasks, patient self assessment</td><td align="left">12 (75%)</td><td align="left">not reported</td><td align="left">short-lasting foot dystonia (1)</td></tr><tr><td align="left">Gbadamosi et al. 2001 [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="left">14</td><td align="left">open label</td><td align="left">ondansetron (iv.) 8 mg (single dose)</td><td align="left">nine-hole peg-test, writing tasks, patient self assessment</td><td align="left" colspan="2">no effect</td><td align="left">none reported</td></tr><tr><td align="left">Aisen et al. 1991 [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td align="left">6</td><td align="left">open label</td><td align="left">Gluthetimide 750 to 1250 mg</td><td align="left">blinded functional assessment by occupational therapist, computer-aided tracking tasks</td><td align="left">5 (83%)</td><td align="left">5 (83%)</td><td align="left">sedation (4)</td></tr><tr><td align="left">Clifford, 1983 [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td align="left">8</td><td align="left">open label</td><td align="left">&#x394;<sup>9</sup>-THC (po.) 5 to 15 mg</td><td align="left">clinical examination</td><td align="left">5 (63%)</td><td align="left">2 (25%)</td><td align="left">none</td></tr><tr><td align="left">Zajicek et al. 2003 [<xref ref-type="bibr" rid="CR103">103</xref>]</td><td align="left">365&#x2020;</td><td align="left">double-blind randomized placebo controlled</td><td align="left">cannabis extract (po.) &#x394;<sup>9</sup>-THC (po.)</td><td align="left">patient self assessment</td><td align="left" colspan="2">no effect</td><td align="left">cannabis extract: adverse events in 12 &#x394;9-THC: adverse events in18 placebo: adverse events in 20</td></tr><tr><td align="left">Wade et al. 2004 [<xref ref-type="bibr" rid="CR92">92</xref>]</td><td align="left">13&#x2021;</td><td align="left">double-blind randomized placebo controlled</td><td align="left">cannabis extract (po.)</td><td align="left">visual analogue scale symptom reduction</td><td align="left" colspan="2">no effect</td><td align="left">cannabis extract:$ 112 adverse events in 80 patients placebo:$ 53 adverse events in 80 patients</td></tr><tr><td align="left">Fox et al. 2004 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td align="left">14</td><td align="left">double-blind randomized placebo controlled crossover</td><td align="left">cannabis extract (po.)</td><td align="left">tremor rating scale</td><td align="left" colspan="2">no effect</td><td align="left">cannabis extract: adverse events in 10 placebo: adverse events in 2</td></tr></tbody></table><table-wrap-foot><p>THC&#xA0;=&#xA0;tetrahydrocannabinol</p><p>* MS patients completing the study</p><p>** in this study, one additional patient was withdrawn because of a severe adverse event (dyspnoea, fever, rash, obtundation)</p><p>&#x2020; the main topic of the study is the effect of cannabinoids on spasticity in MS, the patients were asked to assess treatment effect on other symptoms</p><p>&#x2021; in this study, patients were asked to name their most troublesome symptom; of the 160 included patients, 13 named tremor</p><p>$ No details are reported on the subgroup of the 13 tremulous patients, the total number of adverse events is reported for the whole groups on active treatment and on placebo (80 patients in each group)</p></table-wrap-foot></table-wrap></p>
        <p>Beneficial effects have been reported for a variety of drugs: case reports and small uncontrolled open label studies claim a positive effect of primidone [<xref ref-type="bibr" rid="CR47">47</xref>], gluthetimide [<xref ref-type="bibr" rid="CR2">2</xref>], intrathecal baclofen [<xref ref-type="bibr" rid="CR96">96</xref>] and isoniazid. [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR38">38</xref>] Controlled clinical trials have been published on the use of propranolol [<xref ref-type="bibr" rid="CR52">52</xref>], ethanol [<xref ref-type="bibr" rid="CR52">52</xref>], isoniazid, [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] carbamazepine [<xref ref-type="bibr" rid="CR86">86</xref>], ondansetron [<xref ref-type="bibr" rid="CR78">78</xref>] and dolasetron [<xref ref-type="bibr" rid="CR65">65</xref>].</p>
        <p>Koller evaluated the effect of propranolol, isoniazid and ethanol on tremor in three tremulous MS patients in a double blind crossover trial and found no treatment effect for any of the treatments [<xref ref-type="bibr" rid="CR52">52</xref>]. To the best of our knowledge, no further trials with propranolol have been published, but it is interesting to note that Alusi and coworkers excluded two tremulous MS patients from a thalamotomy trial because they had achieved functional improvement after propranolol use [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
        <p>In an open study the hypnotic-sedative drug glutethimide exhibited visible functional benefit in six of eight MS patients with tremor [<xref ref-type="bibr" rid="CR2">2</xref>]. Apparently, a controlled trial to confirm these findings was never undertaken.</p>
        <p>Two double-blind placebo-controlled trials using isoniazid were published. In the first study reduction of tremor occurred in six of eight patients [<xref ref-type="bibr" rid="CR16">16</xref>], with functional improvement in four patients. In the second study all six patients had measurable tremor reduction after treatment with isoniazid but this did not lead to functional improvement [<xref ref-type="bibr" rid="CR44">44</xref>]. Doses of isoniazid used to treat MS-related tremor were very high (up to 1200 mg a day), and treatment was in some patients associated with anorexia and nausea [<xref ref-type="bibr" rid="CR38">38</xref>] or with a combination of drowsiness, dysphagia and increased bronchial secretion. [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR67">67</xref>] Other reported side effects were abnormal liver function tests, [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] fatigue [<xref ref-type="bibr" rid="CR32">32</xref>] and increased weakness [<xref ref-type="bibr" rid="CR67">67</xref>]. Isoniazid inhibits GABA aminotransferase activity and increases GABA in the central nervous system, but no correlation was found between the degree of GABA elevation in the cerebrospinal fluid and clinical response [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
        <p>Sechi and coworkers published a small single-blind placebo-controlled trial with carbamazepine [<xref ref-type="bibr" rid="CR86">86</xref>]. They reported improvement of tremor as assessed by clinical examination and accelerometry in all seven included patients, but failed to report whether this translated into functional improvement.</p>
        <p>A placebo controlled, double-blind, crossover study, suggested that a single intravenous dose of the 5-HT<sub>3</sub> receptor antagonist ondansetron led to tremor reduction in twelve, and to functional improvement in nine of the sixteen included tremulous MS patients [<xref ref-type="bibr" rid="CR78">78</xref>]. A subsequent open label study by Gbadamosi and colleagues which used the same intervention found no significant treatment effect [<xref ref-type="bibr" rid="CR39">39</xref>]. Likewise, a small clinical trial with dolasetron, another 5-HT<sub>3</sub> receptor antagonist, showed no significant treatment effect on cerebellar ataxia [<xref ref-type="bibr" rid="CR65">65</xref>].</p>
        <p>Weiss and coworkers reported a positive effect of intrathecal baclofen in a single patient with bilateral arm tremor [<xref ref-type="bibr" rid="CR96">96</xref>]. The tremor amplitude decreased almost linearly as the dosage increased and tremor was abolished at a dosage of 250&#xA0;&#xB5;g per day. This possible treatment option has, however, not been observed or evaluated in other studies.</p>
        <p>In recent years, there has been growing interest in cannabis as a possible therapeutic in MS. In the 1980&#x2019;s a case report [<xref ref-type="bibr" rid="CR63">63</xref>] and a small uncontrolled study [<xref ref-type="bibr" rid="CR21">21</xref>] on the beneficial effects of cannabis on tremor and spasticity in MS were published and a survey taken among MS patients revealed that many patients experienced positive effects of smoked cannabis on MS-related symptoms [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
        <p>Baker and colleagues reported a decrease of tremor and spasticity in an animal model of MS after treatment with &#x394;<sup>9</sup>-tetrahydrocannabinol, the active ingredient of cannabis [<xref ref-type="bibr" rid="CR12">12</xref>]. All this furthered hopes of cannabis as a possible new treatment option for tremor in MS, but much to the disappointment of tremulous MS patients, several well conducted randomized controlled trials did not show a significant effect of orally administered cannabis extracts [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR92">92</xref>] or oral &#x394;<sup>9</sup>-tetrahydrocannabinol [<xref ref-type="bibr" rid="CR103">103</xref>] on tremor.</p>
      </sec>
      <sec id="Sec8">
        <title>Surgical treatment</title>
        <p>The surgical treatment options for tremor in MS are stereotactic thalamotomy and DBS. An overview of the published studies on surgical treatment is given in Tables&#xA0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. Most of the studies are small observational retrospective studies. When reviewing the literature on surgical treatment, it is surprising as well as disappointing that the majority of studies are remarkably imprecise in providing basic information on the length of follow-up, on adverse effects and-most importantly-on the effect on functional status and tremor associated disability.
<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Studies on stereotactic surgery for the treatment of tremor in MS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="left">n*</th><th align="left">patient characteristics**</th><th align="left">lesion site</th><th align="left">follow-up</th><th align="left">tremor and disability assessment</th><th align="left">patients with tremor reduction (%)&#xA7;</th><th align="left">patients with improved functional status (%)&#xA7;</th><th align="left">patients with permanent adverse effects (n)</th></tr></thead><tbody><tr><td align="left">Cooper, 1960a [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">2</td><td align="left">disabling intention tremor</td><td align="left">VL</td><td align="left">3 to 12 mo</td><td align="left">clinical examination</td><td align="left">2 (100%)</td><td align="left">not reported</td><td align="left">none</td></tr><tr><td align="left">Cooper, 1960b [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">6</td><td align="left">disabling intention tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;5) or bilateral (n&#xA0;=&#xA0;1) VL</td><td align="left">Not specifically reported</td><td align="left">clinical examination, assessment of filmed tremor</td><td align="left">5 (83%)</td><td align="left">not reported</td><td align="left">increase of contralateral hemiparesis (1)</td></tr><tr><td align="left">Krayenb&#xFC;hl et al. 1962 [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td align="left">4</td><td align="left">disabling bilateral intention tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;3) or bilateral (n&#xA0;=&#xA0;1) VL</td><td align="left">3 weeks to 6 mo</td><td align="left">clinical examination</td><td align="left">4 (100%)</td><td align="left">4 (100%)</td><td align="left">none</td></tr><tr><td align="left">Broager and Fog, 1962 [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td align="left">4</td><td align="left">severe intention tremor</td><td align="left">unilateral VL</td><td align="left">1 to 6 mo</td><td align="left">clinical examination</td><td align="left">4 (100%)</td><td align="left">2 (50%)</td><td align="left">generalized seizure (1) mental change (1)</td></tr><tr><td align="left">Cooper et al. 1967 [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td align="left">32</td><td align="left">disabling bilateral intention tremor</td><td align="left">unilateral or bilateral VL</td><td align="left">12 to 96 mo</td><td align="left">clinical examination</td><td align="left">27 (85%)</td><td align="left">not reported</td><td align="left">increase of contralateral hemiparesis (2)</td></tr><tr><td align="left">Samra et al. 1970 [<xref ref-type="bibr" rid="CR81">81</xref>]</td><td align="left">25</td><td align="left">disabling bilateral arm intention tremor</td><td align="left">unilateral or bilateral VL</td><td align="left">not specifically reported</td><td align="left">clinical examination, assessment of filmed tremor</td><td align="left">22 (88%)</td><td align="left">not reported</td><td align="left">increase of contralateral hemiparesis (1)</td></tr><tr><td align="left">Riechert and Richter, 1972 [<xref ref-type="bibr" rid="CR79">79</xref>]</td><td align="left">29</td><td align="left">disabling intention (n&#xA0;=&#xA0;29) and postural (n&#xA0;=&#xA0;18) tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;28) or bilateral (n&#xA0;=&#xA0;1) VL</td><td align="left">not specifically reported</td><td align="left">clinical examination, patient self assessment questionnaires</td><td align="left">29 (100%)</td><td align="left">&#x201C;two thirds&#x201D; of patients</td><td align="left">increase of leg paresis (2)</td></tr><tr><td align="left">Arsalo et al. 1973 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td align="left">26</td><td align="left">disabling bilateral intention tremor</td><td align="left">unilateral VL and subthalamus</td><td align="left">3 to 97 mo</td><td align="left">clinical examination</td><td align="left">21 (80%)</td><td align="left">not reported</td><td align="left">subdural haematoma (1)</td></tr><tr><td align="left">Andrew et al. 1974 [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td align="left">4</td><td align="left">disabling postural (n&#xA0;=&#xA0;2) and intention (n&#xA0;=&#xA0;4) tremor</td><td align="left">unilateral VIM</td><td align="left">6 to 36 mo</td><td align="left">clinical examination</td><td align="left">4 (100%)</td><td align="left">not reported</td><td align="left">hemiplegia (1)</td></tr><tr><td align="left">Van Manen, 1974 [<xref ref-type="bibr" rid="CR91">91</xref>]</td><td align="left">4</td><td align="left">severe intention tremor</td><td align="left">unilateral VL</td><td align="left">3 to 86 mo&#x2020;</td><td align="left">clinical examination</td><td align="left">2 (50%)</td><td align="left">not reported</td><td align="left">not reported separately for MS subgroup</td></tr><tr><td align="left">Hauptvogel et al. 1975 [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td align="left">11</td><td align="left">severe intention tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;10) or bilateral (n&#xA0;=&#xA0;1) VL</td><td align="left">15 to 86 mo</td><td align="left">clinical examination</td><td align="left">7 (63%)</td><td align="left">4 (36%)</td><td align="left">not reported</td></tr><tr><td align="left">Mundinger and Kuhn 1982 [<xref ref-type="bibr" rid="CR68">68</xref>]</td><td align="left">84</td><td align="left">severe action tremor</td><td align="left">ZI, VOP</td><td align="left">36 to 120 mo</td><td align="left">clinical examination filmed tremor patient self assessment questionnaire</td><td align="left">70 (83%)</td><td align="left">not reported</td><td align="left">not specifically reported</td></tr><tr><td align="left">Speelman and van Manen, 1984 [<xref ref-type="bibr" rid="CR89">89</xref>]</td><td align="left">11</td><td align="left">severe intention tremor</td><td align="left">unilateral VL</td><td align="left">3 weeks to 132 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">8 (73%)</td><td align="left">0 (0%)</td><td align="left">hemiparesis (4) micturition disturbance (2) speech disorder (1)</td></tr><tr><td align="left">Kandel and Hondcarian, 1985 [<xref ref-type="bibr" rid="CR51">51</xref>]</td><td align="left">20</td><td align="left">severe intention tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;15) or bilateral (n&#xA0;=&#xA0;5) VL (ZI, FF)</td><td align="left">12 to 120 mo</td><td align="left">not reported</td><td align="left">14 (70%)</td><td align="left">not reported</td><td align="left">none</td></tr><tr><td align="left">Hitchcock et al. 1987 [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td align="left">30</td><td align="left">tremor</td><td align="left">Thalamus</td><td align="left">24 mo</td><td align="left">clinical examination functional rating scales</td><td align="left">50%</td><td align="left">25%</td><td align="left">not reported</td></tr><tr><td align="left">Wester et al. 1990 [<xref ref-type="bibr" rid="CR97">97</xref>]</td><td align="left">9</td><td align="left">severe intention tremor</td><td align="left">unilateral VOA and VOP</td><td align="left">3 to 89 mo mean: 24 mo&#x2020;</td><td align="left">questionnaire sent to treating neurologist</td><td align="left">6 (66%)</td><td align="left">6 (66%)</td><td align="left">hemiparesis (5) mental changes (3) dysphasia (3) dysarthria (2) subdural haematoma (1)</td></tr><tr><td align="left">Goldman et al. 1992 [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td align="left">2</td><td align="left">severe intention tremor unresponsive to medication</td><td align="left">unilateral VL</td><td align="left">3 mo 34 mo</td><td align="left">clinical tremor rating scale</td><td align="left">2 (100%)</td><td align="left">0 (0%)</td><td align="left">dysarthria (1)</td></tr><tr><td align="left">Whittle and Haddow, 1995 [<xref ref-type="bibr" rid="CR98">98</xref>]</td><td align="left">9</td><td align="left">severe rest, kinetic, postural or intention tremor</td><td align="left">unilateral VL</td><td align="left">12 mo</td><td align="left">clinical examination and evauation of video tapes</td><td align="left">9 (100%)</td><td align="left">2 (22%)</td><td align="left">depression (2)</td></tr><tr><td align="left">Shahzadi et al. 1995 [<xref ref-type="bibr" rid="CR87">87</xref>]</td><td align="left">33</td><td align="left">severe tremor</td><td align="left">unilateral VIM</td><td align="left">3 to 120 mo</td><td align="left">clinical examination ability to drink from a waterfilled cup</td><td align="left">22 (67%)</td><td align="left">17 (51%)</td><td align="left">not reported</td></tr><tr><td align="left">Hooper and Whittle, 1998 [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td align="left">6</td><td align="left">severe postural (n&#xA0;=&#xA0;4) or intention tremor (n&#xA0;=&#xA0;2)</td><td align="left">unilateral VL</td><td align="left">14 to 73 mo mean: 51 mo</td><td align="left">Barthel Index</td><td align="left">1 (16%)</td><td align="left">1 (16%)</td><td align="left">not reported</td></tr><tr><td align="left">Critchley and Richardson, 1998 [<xref ref-type="bibr" rid="CR27">27</xref>]</td><td align="left">24</td><td align="left">disabling intention tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;22) or bilateral (n&#xA0;=&#xA0;2) VIM</td><td align="left">mean: 26 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">18 (75%)</td><td align="left">2 (8%)</td><td align="left">hemiparesis (1) seizure (2) MS relapse (3) dysarthria (1)</td></tr><tr><td align="left">Schuurman et al. 2000 [<xref ref-type="bibr" rid="CR85">85</xref>]</td><td align="left">5</td><td align="left">severe arm tremor</td><td align="left">unilateral VIM&#x2021;</td><td align="left">6 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">5 (100%)</td><td align="left">0 (0%)</td><td align="left">severe gait or balance disturbance (2)</td></tr><tr><td align="left">Niranjan et al. 2000 [<xref ref-type="bibr" rid="CR72">72</xref>]***</td><td align="left">3</td><td align="left">severe action tremor</td><td align="left">unilateral VIM</td><td align="left">2 to 11 mo median 6 mo&#x2020;</td><td align="left">clinical tremor rating scale, patient self assessment of functional improvement</td><td align="left">3 (100%)</td><td align="left">3 (100%)</td><td align="left">none</td></tr><tr><td align="left">Alusi et al. 2001 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td align="left">11</td><td align="left">severe postural and intention tremor</td><td align="left">unilateral VOP (n&#xA0;=&#xA0;7), ZI (n&#xA0;=&#xA0;3), STN (n&#xA0;=&#xA0;1)</td><td align="left">12 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">11 (100%)</td><td align="left">7 (64%)</td><td align="left">depression (3) seizures (2) hemiparesis (1) dysphasia (1)</td></tr><tr><td align="left">Matsumoto et al. 2001 [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left">6</td><td align="left">severe tremor</td><td align="left">unilateral VIM</td><td align="left">3 to 12 mo</td><td align="left">clinical tremor and functional rating scales, novel movement analysis tool</td><td align="left">6 (100%)</td><td align="left">0 (0%)</td><td align="left">MS relapse (2)</td></tr><tr><td align="left">Bittar et al. 2005 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left">10</td><td align="left">disabling postural and intention arm tremor</td><td align="left">unilateral VOP (distal tremor), unilateral ZI (proximal tremor) or unilateral VOP and ZI (mixed tremor)</td><td align="left">12 to 50 mo: mean 16 mo</td><td align="left">clinical tremor rating scale</td><td align="left">not individually reported, overall improvement of mean tremor scores: postural: 78% intention: 72%</td><td align="left">not reported</td><td align="left">hemiparesis (3) seizures (1)</td></tr></tbody></table><table-wrap-foot><p>VOP&#xA0;=&#xA0;nucleus ventralis oralis posterior; VOA&#xA0;=&#xA0;nucleus ventralis oralis anterior; VIM&#xA0;=&#xA0;nucleus ventralis intermedius; ZI&#xA0;=&#xA0;zona incerta; VL&#xA0;=&#xA0;nucleus ventralis lateralis; STN&#xA0;=&#xA0;nucleus subthalamicus; FF&#xA0;=&#xA0;Forel&#x2019;s Field</p><p>* MS patients with completed surgical intervention and remaining in the study until end of follow up</p><p>** an effort is made to distinguish between predominance of intention or postural tremor although many terms to describe tremor subtypes are used in the studies</p><p>*** In this study, gamma-knife radiosurgery is used</p><p>&#xA7; improvement as described in case reports or measured at the end of follow-up on any scale used in the study</p><p>&#x2020; in this study, MS patients were grouped together with patients with other movement disorders, no details are given for the MS-subgroup</p><p>&#x2021; thalamotomy was followed six months later by contralateral DBS electrode implantation in patients with bilateral tremor</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table&#xA0;4</label><caption><p>Studies on DBS for the treatment of tremor in MS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="left">N*</th><th align="left">patient characteristics</th><th align="left">stimulation site</th><th align="left">follow-up</th><th align="left">tremor and disability assessment</th><th align="left">patients with tremor reduction (%)&#xA7;</th><th align="left">patients with improved functional status (%)&#xA7;</th><th align="left">patients with permanent adverse effects (n)</th></tr></thead><tbody><tr><td align="left">Brice and McLellan, 1980 [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td align="left">2</td><td align="left">severe bilateral arm intention tremor</td><td align="left">bilateral subthalamic</td><td align="left">5 mo 6 mo</td><td align="left">clinical examination</td><td align="left">2 (100%)</td><td align="left">2 (100%)</td><td align="left">**</td></tr><tr><td align="left">Nguyen and Degos, 1993 [<xref ref-type="bibr" rid="CR71">71</xref>]</td><td align="left">1</td><td align="left">severe unilateral distal postural arm tremor</td><td align="left">unilateral VIM</td><td align="left">17 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">1 (100%)</td><td align="left">1 (100%)</td><td align="left">not reported</td></tr><tr><td align="left">Siegfried and Lippitz, 1994 [<xref ref-type="bibr" rid="CR88">88</xref>]</td><td align="left">9</td><td align="left">severe intention tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;8) or bilateral (n&#xA0;=&#xA0;1) VIM</td><td align="left">not reported</td><td align="left">not reported</td><td align="left">9 (100%)</td><td align="left">not reported</td><td align="left">not reported</td></tr><tr><td align="left">Benabid et al. 1996 [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td align="left">4</td><td align="left">severe arm tremor&#x2020;</td><td align="left">VIM&#x2020;</td><td align="left">&#x2265; 6 mo</td><td align="left">clinical tremor rating scale</td><td align="left">0 (0%)&#x2021;</td><td align="left">no detailed report&#x2020;</td><td align="left">intracerebral haemorrhage (1)</td></tr><tr><td align="left">Geny et al. 1996 [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left">13</td><td align="left">severe postural tremor (n&#xA0;=&#xA0;12), moderate intention tremor (n&#xA0;=&#xA0;1)</td><td align="left">unilateral VIM</td><td align="left">8 to 26 mo mean: 13 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">9 (69%)</td><td align="left">12 (92%)</td><td align="left">MS relapse (3)</td></tr><tr><td align="left">Whittle et al. 1998 [<xref ref-type="bibr" rid="CR99">99</xref>]***</td><td align="left">5</td><td align="left">severe arm tremor</td><td align="left">VL</td><td align="left">not reported</td><td align="left">not reported</td><td align="left">not reported</td><td align="left">not reported</td><td align="left">not reported</td></tr><tr><td align="left">Hay, 1999 [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td align="left">1</td><td align="left">head and limb tremor</td><td align="left">unilateral thalamus</td><td align="left">2 mo</td><td align="left">not reported</td><td align="left">1 (100%)</td><td align="left">not reported</td><td align="left">not reported</td></tr><tr><td align="left">Montgomery et al, 1999 [<xref ref-type="bibr" rid="CR66">66</xref>]</td><td align="left">14</td><td align="left">disabling arm tremor</td><td align="left">unilateral VIM</td><td align="left">variable</td><td align="left">clinical tremor rating scale</td><td align="left">15 (100%)</td><td align="left">not reported</td><td align="left">MS relapse (1)#</td></tr><tr><td align="left">Schulder et al. 1999 [<xref ref-type="bibr" rid="CR83">83</xref>]</td><td align="left">5</td><td align="left">severe bilateral postural and intention arm tremor</td><td align="left">unilateral VIM</td><td align="left">&gt;6 mo</td><td align="left">clinical tremor rating scale, patient self assessment of functional improvement</td><td align="left">5 (100%)</td><td align="left">3 (60%)</td><td align="left">Ms relapse (2)</td></tr><tr><td align="left">Taha et al. 1999 [<xref ref-type="bibr" rid="CR90">90</xref>]</td><td align="left">2</td><td align="left">bilateral limb, head or voice tremor&#x2020;</td><td align="left">bilateral VIM (bilateral DBS or unilateral DBS plus contralateral thalamotomy)</td><td align="left">mean: 10 mo</td><td align="left">clinical tremor rating scale</td><td align="left">2 (100%)</td><td align="left">not reported</td><td align="left">not reported separately for MS subgroup&#x2020;</td></tr><tr><td align="left">Schuurman et al. 2000 [<xref ref-type="bibr" rid="CR85">85</xref>]</td><td align="left">5</td><td align="left">severe arm tremor</td><td align="left">unilateral or bilateral VIM</td><td align="left">6 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">3&#x2013;5 (60&#x2013;100%)$</td><td align="left">0 (0%)</td><td align="left">dysarthria (2) severe gait or balance disturbance (1) arm ataxia (1)</td></tr><tr><td align="left">Krauss et al. 2001 [<xref ref-type="bibr" rid="CR53">53</xref>] Loher et al. 2003 [<xref ref-type="bibr" rid="CR61">61</xref>]$$</td><td align="left">2</td><td align="left">severe tremor</td><td align="left">unilateral or bilateral VIM&#x2020;</td><td align="left">3 to 24 mo, mean: 12 mo&#x2020;</td><td align="left">clinical tremor rating scales, assessment of video tapes</td><td align="left">2 (100%)</td><td align="left">not reported</td><td align="left">not reported separately for MS subgroup&#x2020;</td></tr><tr><td align="left">Matsumoto et al. 2001 [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left">3</td><td align="left">severe tremor</td><td align="left">unilateral VIM</td><td align="left">3 to 12 mo</td><td align="left">clinical tremor and functional rating scales, novel movement analysis tool</td><td align="left">3 (100%)</td><td align="left">0 (0%)</td><td align="left">none</td></tr><tr><td align="left">Hooper et al. 2002 [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td align="left">10</td><td align="left">disabling arm tremor</td><td align="left">unilateral thalamus</td><td align="left">12 mo</td><td align="left">clinical tremor and functional rating scales</td><td align="left">10 (100%)</td><td align="left">0 (0%)</td><td align="left">intracerebral haemorrhage (2) generalized seizure (2)</td></tr><tr><td align="left">Nandi et al. 2002 [<xref ref-type="bibr" rid="CR70">70</xref>]</td><td align="left">1</td><td align="left">severe bilateral postural and intention tremor</td><td align="left">unilateral ZI</td><td align="left">12 mo</td><td align="left">clinical examination</td><td align="left">1 (100%)</td><td align="left">1 (100%)</td><td align="left">increased dystonic posturing of left foot impairing ambulation (1)</td></tr><tr><td align="left">Berk et al. 2002 [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">12</td><td align="left">disabling arm tremor</td><td align="left">unilateral VIM</td><td align="left">12 mo</td><td align="left">clinical tremor and functional rating scales, patient self assessment questionnaire</td><td align="left">significant tremor reduction, not individually reported</td><td align="left">no significant improvement</td><td align="left">wound infection (2)</td></tr><tr><td align="left">Wishart et al. 2003 [<xref ref-type="bibr" rid="CR102">102</xref>]</td><td align="left">4</td><td align="left">bilateral arm tremor</td><td align="left">bilateral VL</td><td align="left">15 to 31 mo</td><td align="left">clinical tremor rating scale</td><td align="left">4 (100%)</td><td align="left">4 (100%)</td><td align="left">MS relapse (1) dysarthria (1)</td></tr><tr><td align="left">Schulder et al. 2003 [<xref ref-type="bibr" rid="CR84">84</xref>]</td><td align="left">9</td><td align="left">disabling arm tremor</td><td align="left">unilateral thalamus</td><td align="left">9 to 48 mo,</td><td align="left">clinical tremor and functional rating scales, patient self assessment</td><td align="left">8 (88%)</td><td align="left">3 (33%)</td><td align="left">MS relapse (3)</td></tr><tr><td align="left">Nandi et al. 2004 [<xref ref-type="bibr" rid="CR69">69</xref>]</td><td align="left">10</td><td align="left">disabling arm tremor</td><td align="left">unilateral (n&#xA0;=&#xA0;6) or bilateral (n&#xA0;=&#xA0;4) VOP and ZI</td><td align="left">3 to 23 mo</td><td align="left">computer-aided tracking tasks</td><td align="left">significant tremor reduction, not individually reported</td><td align="left">not reported</td><td align="left">seizure (1) dysarthria (1) wound infection (1)</td></tr><tr><td align="left">Bittar et al. 2005 [<xref ref-type="bibr" rid="CR15">15</xref>]y</td><td align="left">10</td><td align="left">disabling postural and intention arm tremor</td><td align="left">unilateral VOP (distal tremor), unilateral ZI (proximal tremor) or unilateral VOP and ZI (mixed tremor)</td><td align="left">3 to 23 mo:</td><td align="left">clinical tremor rating scale</td><td align="left">not individually reported, overall improvement of mean tremor scores: postural: 64% intention: 36%</td><td align="left">not reported</td><td align="left">monoparesis (1)</td></tr></tbody></table><table-wrap-foot><p>VIM&#xA0;=&#xA0;nucleus ventralis intermedius; ZI&#xA0;=&#xA0;zona incerta; VL&#xA0;=&#xA0;nucleus ventralis lateralis</p><p>* MS patients with completed surgical intervention and remaining in the study until the end of follow up</p><p>&#xA7; improvement as described in case reports or measured at the end of follow-up on any scale used in the study</p><p>** in this study two patients had complete surgery and in three, surgery was aborted. A worsening of dysarthria is reported in one patient, it is unclear whether this patients had completed surgery</p><p>*** This study mostly discusses difficulties in target localisation and patient selection</p><p># in this study, one patient did not complete surgery due to an intraoperative VIM haemorrhage</p><p>&#x2020; in this study, MS patients were grouped together with patients with other movement disorders, no details are given for the MS-subgroup</p><p>&#x2021; For the whole group, tremor was &#x201C;inconsistently, less significantly [than tremor of Parkinson&#x2019;s Disease and essential tremor] or not improved. If improvement was achieved it lasted only a few months&#x201D;</p><p>$ The exact number of patients with improved tremor cannot be ascertained the way the data is presented in this study</p><p>$$ Both studies are on one patient cohort, the relevant data on MS patients are derived from both studies</p></table-wrap-foot></table-wrap></p>
        <p>The first study on thalamotomy for tremor in MS was published by Cooper in 1960 [<xref ref-type="bibr" rid="CR25">25</xref>]. Brice and colleagues were the first to report improvement of tremor through continuous thalamic DBS in 1980 [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      </sec>
      <sec id="Sec9">
        <title>Strategies for patient and treatment site selection</title>
        <p>The earlier studies on thalamotomy used the thalamic nucleus ventralis lateralis (VL) as the target, whereas the nucleus VIM was chosen in most DBS studies and most later thalamotomy studies. This preference for the VIM is probably due to the experience with this thalamic nucleus in the treatment of tremor in Parkinson&#x2019;s disease (PD) and essential tremor (ET). Research groups in Oxford and London used the nucleus VOP and the zona incerta (ZI) as targets for both lesional surgery and DBS, but the results yielded with these targets [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] were not different from those reported for VIM or VL thalamotomy or stimulation.</p>
        <p>The same researchers advocate the use of tremor frequency analysis during movement tasks as a method to identify patients likely to benefit from surgery [<xref ref-type="bibr" rid="CR60">60</xref>]. This may be a valuable tool for patient selection, although it has only been validated in a small number of patients and studies in which this technique is used [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] do not report better results than studies without this selection method.</p>
        <p>The site for lesional surgery or electrode placement is classically chosen relative to the site of the anterior and posterior commissures using a standardized atlas. More recently, surgeons tried to refine this placement strategy with microelectrode recording within the target area. Neurons discharging synchronous to peripheral tremor are identified and the treatment site is placed in an area where the most tremor related neuronal activity is found. [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]</p>
        <p>This method of treatment site selection is often used in studies on tremulous patients with PD and ET, but only a small number of MS-patients were included in these studies. [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] Since this method offers a theoretical advantage over the classical methods of treatment site selection, it should be further evaluated.</p>
      </sec>
      <sec id="Sec10">
        <title>Outcome after surgical treatment</title>
        <p>Because of the many shortcomings of the published studies, the results need to be interpreted with great caution. It does, however, seem as if almost all patients experience tremor reduction immediately after thalamotomy, and roughly 70% of patients continue to benefit from thalamotomy beyond a follow-up period of one year (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>). In the three studies on thalamic DBS with a follow-up period longer than one year, 69% to 100% of the patients experienced reduced tremor [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Functional improvement after both thalamotomy and DBS is much more variable and unfortunately not reported in many studies (Tables&#xA0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>).</p>
        <p>Niranjan published an interesting study on gamma-knife thalamotomy as a possible alternative to neurosurgery. In this study all three patients with MS-related tremor experienced marked improvement of tremor after radiosurgery. Unfortunately, no further studies have been published to evaluate this interesting non-invasive treatment option [<xref ref-type="bibr" rid="CR72">72</xref>].</p>
        <p>There are two trials in which thalamotomy and DBS were compared in patients with MS. In a randomized controlled trial conducted by Schuurman and colleagues [<xref ref-type="bibr" rid="CR85">85</xref>] patients with ET, tremor due to PD and tremulous MS patients were randomized to undergo either VIM thalamotomy or DBS. Five tremulous MS patients were randomized to each group. After a short follow-up period of six months, there were no significant differences between thalamotomy and DBS in functional outcome for the MS subgroup. In the same study, fewer adverse effects were observed in the DBS group, except for the subgroup of MS patients, where adverse effects were about equal for both interventions (Tables&#xA0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>). Bittar and colleagues compared cumulative tremor scores for intention and postural tremor between patients undergoing VOP/ZI thalamotomy or DBS in a non-randomized study [<xref ref-type="bibr" rid="CR15">15</xref>]. Ten patients were in each group. Interestingly, after a mean follow-up period of 15 to 16 months, patients in the thalamotomy group had a better outcome (tremor reduction: 78% for postural tremor and 72% for intention tremor) than patients in the DBS group (tremor reduction: 64% for postural tremor and 36% for intention tremor). However, as there were more adverse effects in the thalamotomy group, no clear recommendations could be given.</p>
        <p>Adverse events reported for the neurosurgical interventions comprised increase of hemiparesis, dysarthria, dysphasia, mental changes, depression, seizures, intracerebral haemorrhage, subdural haematoma, wound infection and MS relapse. Thalamotomy was associated with a higher risk of adverse events than DBS. Bilateral thalamotomy carries such a high risk of adverse effects, that it is no longer recommended. If bilateral treatment is necessary, either bilateral DBS or unilateral thalamotomy followed by contralateral DBS are possible treatment options.</p>
      </sec>
      <sec id="Sec11">
        <title>Other treatment options</title>
        <p>Electromagnetic fields, limb cooling, physiotherapy, weight bracelets, orthoses and specialized software have been advocated as additional treatment options.</p>
        <p>Sandyk and Dann reported a reduction of intention as well as postural tremor in three tremulous MS patients treated with pulsed electromagnetic fields [<xref ref-type="bibr" rid="CR82">82</xref>], but these interesting findings have not been substantiated in a larger trial.</p>
        <p>Albrecht and coworkers published a small clinical trial on the effect of arm cooling on intention tremor [<xref ref-type="bibr" rid="CR3">3</xref>]. In their study, patients achieved significantly better results on a clinical testing battery after immersion of the tremulous arm in ice water. As this effect lasted for about 45 minutes the authors recommend limb cooling to achieve transient tremor control for activities such as working with a PC, signing a document or self-catherisation. In a similar study, Feys and colleagues report tremor reduction lasting for about 30 minutes after limb cooling with a special cooling device [<xref ref-type="bibr" rid="CR35">35</xref>].</p>
        <p>Weighted wrist cuffs are a mechanical tool to reduce tremor amplitude, and one article reported their beneficial effects in three MS patients [<xref ref-type="bibr" rid="CR28">28</xref>]. Although wearing bracelets decrease tremor amplitude and therefore may offer some benefit to tremulous patients, their effect on intention tremor is small and their use is therefore unlikely to yield important functional improvement. A more advanced computer aided tremor reducing orthosis provided functional benefit in a small case series including patients with MS [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
        <p>Physiotherapy aimed at improving ataxia in MS was evaluated by Armutlu and coworkers. In their small pilot study they found that rehabilitative physiotherapy using Johnstone pressure splints was superior to physiotherapy alone [<xref ref-type="bibr" rid="CR9">9</xref>]. Unfortunately no larger trials followed this pilot study, so that it remains uncertain which patients may benefit from which form of physiotherapy.</p>
        <p>The use of a mouse driven computer system is a special challenge for tremulous MS patients. Feys and colleagues published a study on the use of specialized software developed to aid computer use in 36 tremulous MS patients and found significant improvement in the time needed to complete some basic mouse driven computer operations [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec12" sec-type="conclusion">
      <title>Conclusion</title>
      <p>The treatment of tremor remains a great challenge for everyone caring for patients with MS. Drug treatment with currently available medication is unsuccessful in most cases and much more research on the pathophysiology and biochemistry of tremor production in MS will be necessary before an efficient medical treatment can be developed. Stereotactic surgery can be an effective means to treat severe tremor, but it is currently uncertain whether lesional surgery or DBS is the treatment of choice. Larger clinical trials comparing both interventions are needed. Other treatment options, including physiotherapy, tremor reducing orthoses, and limb cooling can lead to valuable improvements in activities of daily living.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aisen</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baiges</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Maxwell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The effect of mechanical damping loads on disabling action tremor</article-title>
          <source>Neurology</source>
          <year>1993</year>
          <volume>43</volume>
          <fpage>1346</fpage>
          <lpage>1350</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M (1993) The effect of mechanical damping loads on disabling action tremor. Neurology 43:1346&#x2013;1350 <pub-id pub-id-type="pmid">8327136</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aisen</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McDowell</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury</article-title>
          <source>Arch Neurol</source>
          <year>1991</year>
          <volume>48</volume>
          <fpage>513</fpage>
          <lpage>515</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aisen ML, Holzer M, Rosen M, Dietz M, McDowell F (1991) Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury. Arch Neurol 48:513&#x2013;515 <pub-id pub-id-type="pmid">2021365</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albrecht</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schwecht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pollmann</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Parag</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Erasmus</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Konig</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Lokale Eisapplikation in der Therapie der gliedkinetischen Ataxie. Klinischer Nachweis positiver Behandlungseffekte bei Patienten mit multipler Sklerose</article-title>
          <source>Nervenarzt</source>
          <year>1998</year>
          <volume>69</volume>
          <fpage>1066</fpage>
          <lpage>1073</lpage>
        </citation>
        <citation citation-type="display-unstructured">Albrecht H, Schwecht M, Pollmann W, Parag D, Erasmus LP, Konig N (1998) Lokale Eisapplikation in der Therapie der gliedkinetischen Ataxie. Klinischer Nachweis positiver Behandlungseffekte bei Patienten mit multipler Sklerose. Nervenarzt 69:1066&#x2013;1073 <pub-id pub-id-type="pmid">9888143</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alusi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>TZ</given-names>
            </name>
            <name>
              <surname>Glickman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jahanshahi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis: a prospective case-controlled study</article-title>
          <source>Brain</source>
          <year>2001</year>
          <volume>124</volume>
          <fpage>1576</fpage>
          <lpage>1589</lpage>
        </citation>
        <citation citation-type="display-unstructured">Alusi SH, Aziz TZ, Glickman S, Jahanshahi M, Stein JF, Bain PG (2001) Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis: a prospective case-controlled study. Brain 124:1576&#x2013;1589 <pub-id pub-id-type="pmid">11459749</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alusi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Glickman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>TZ</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Tremor in multiple sclerosis</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1999</year>
          <volume>66</volume>
          <fpage>131</fpage>
          <lpage>134</lpage>
        </citation>
        <citation citation-type="display-unstructured">Alusi SH, Glickman S, Aziz TZ, Bain PG (1999) Tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 66:131&#x2013;134 <pub-id pub-id-type="pmid">10071088</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alusi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Worthington</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Glickman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>A study of tremor in multiple sclerosis</article-title>
          <source>Brain</source>
          <year>2001</year>
          <volume>124</volume>
          <fpage>720</fpage>
          <lpage>730</lpage>
        </citation>
        <citation citation-type="display-unstructured">Alusi SH, Worthington J, Glickman S, Bain PG (2001) A study of tremor in multiple sclerosis. Brain 124:720&#x2013;730 <pub-id pub-id-type="pmid">11287372</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alusi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Worthington</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Glickman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Findley</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of three different ways of assessing tremor in multiple sclerosis</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2000</year>
          <volume>68</volume>
          <fpage>756</fpage>
          <lpage>760</lpage>
        </citation>
        <citation citation-type="display-unstructured">Alusi SH, Worthington J, Glickman S, Findley LJ, Bain PG (2000) Evaluation of three different ways of assessing tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 68:756&#x2013;760 <pub-id pub-id-type="pmid">10811700</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrew</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rice Edwards</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rudolf</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>The placement of stereotaxic lesions for involuntary movements other than in Parkinson&#x2019;s disease</article-title>
          <source>Acta Neurochir (Wien ) Suppl</source>
          <year>1974</year>
          <volume>21</volume>
          <fpage>39</fpage>
          <lpage>47</lpage>
        </citation>
        <citation citation-type="display-unstructured">Andrew J, Rice Edwards JM, Rudolf NM (1974) The placement of stereotaxic lesions for involuntary movements other than in Parkinson&#x2019;s disease. Acta Neurochir (Wien ) Suppl 21:39&#x2013;47 </citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armutlu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Karabudak</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nurlu</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Physiotherapy approaches in the treatment of ataxic multiple sclerosis: a pilot study</article-title>
          <source>Neurorehabil Neural Repair</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>203</fpage>
          <lpage>211</lpage>
        </citation>
        <citation citation-type="display-unstructured">Armutlu K, Karabudak R, Nurlu G (2001) Physiotherapy approaches in the treatment of ataxic multiple sclerosis: a pilot study. Neurorehabil Neural Repair 15:203&#x2013;211 <pub-id pub-id-type="pmid">11944742</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arsalo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanninen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laitinen</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Functional neurosurgery in the treatment of multiple sclerosis</article-title>
          <source>Ann Clin Res</source>
          <year>1973</year>
          <volume>5</volume>
          <fpage>74</fpage>
          <lpage>79</lpage>
        </citation>
        <citation citation-type="display-unstructured">Arsalo A, Hanninen A, Laitinen L (1973) Functional neurosurgery in the treatment of multiple sclerosis. Ann Clin Res 5:74&#x2013;79 <pub-id pub-id-type="pmid">4748754</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Findley</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Atchison</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Behari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vidailhet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gresty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rothwell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Marsden</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Assessing tremor severity</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1993</year>
          <volume>56</volume>
          <fpage>868</fpage>
          <lpage>873</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M, Rothwell JC, Thompson PD, Marsden CD (1993) Assessing tremor severity. J Neurol Neurosurg Psychiatry 56:868&#x2013;873 <pub-id pub-id-type="pmid">8350102</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pryce</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Croxford</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pertwee</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Huffman</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Layward</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cannabinoids control spasticity and tremor in a multiple sclerosis model</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>404</volume>
          <fpage>84</fpage>
          <lpage>87</lpage>
        </citation>
        <citation citation-type="display-unstructured">Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404:84&#x2013;87 <pub-id pub-id-type="pmid">10716447</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benabid</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Pollak</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Limousin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gay</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Payen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Benazzouz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders</article-title>
          <source>J Neurosurg</source>
          <year>1996</year>
          <volume>84</volume>
          <fpage>203</fpage>
          <lpage>214</lpage>
        </citation>
        <citation citation-type="display-unstructured">Benabid AL, Pollak P, Gao D, Hoffmann D, Limousin P, Gay E, Payen I, Benazzouz A (1996) Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 84:203&#x2013;214 <pub-id pub-id-type="pmid">8592222</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berk</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carr</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sinden</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martzke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Honey</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Thalamic deep brain stimulation for the treatment of tremor due to multiple sclerosis: a prospective study of tremor and quality of life</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>815</fpage>
          <lpage>820</lpage>
        </citation>
        <citation citation-type="display-unstructured">Berk C, Carr J, Sinden M, Martzke J, Honey CR (2002) Thalamic deep brain stimulation for the treatment of tremor due to multiple sclerosis: a prospective study of tremor and quality of life. J Neurosurg 97:815&#x2013;820 <pub-id pub-id-type="pmid">12405368</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bittar</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Hyam</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nandi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Joint</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Gregory</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>TZ</given-names>
            </name>
          </person-group>
          <article-title>Thalamotomy versus thalamic stimulation for multiple sclerosis tremor</article-title>
          <source>J Clin Neurosci</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>638</fpage>
          <lpage>642</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bittar RG, Hyam J, Nandi D, Wang S, Liu X, Joint C, Bain PG, Gregory R, Stein J, Aziz TZ (2005) Thalamotomy versus thalamic stimulation for multiple sclerosis tremor. J Clin Neurosci 12:638&#x2013;642 <pub-id pub-id-type="pmid">16098758</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bozek</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Kastrukoff</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>A controlled trial of isoniazid therapy for action tremor in multiple sclerosis</article-title>
          <source>J Neurol</source>
          <year>1987</year>
          <volume>234</volume>
          <fpage>36</fpage>
          <lpage>39</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bozek CB, Kastrukoff LF, Wright JM, Perry TL, Larsen TA (1987) A controlled trial of isoniazid therapy for action tremor in multiple sclerosis. J Neurol 234:36&#x2013;39 <pub-id pub-id-type="pmid">3546605</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brice</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McLellan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Suppression of intention tremor by contingent deep-brain stimulation</article-title>
          <source>Lancet</source>
          <year>1980</year>
          <volume>315</volume>
          <fpage>1221</fpage>
          <lpage>1222</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brice J, McLellan L (1980) Suppression of intention tremor by contingent deep-brain stimulation. Lancet 315:1221&#x2013;1222 <pub-id pub-id-type="pmid">6104038</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broager</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fog</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Thalamotomy for the relief of intention tremor in multiple sclerosis</article-title>
          <source>Acta Neurol Scand</source>
          <year>1962</year>
          <volume>38</volume>
          <issue>Suppl 3</issue>
          <fpage>153</fpage>
          <lpage>156</lpage>
        </citation>
        <citation citation-type="display-unstructured">Broager B, Fog T (1962) Thalamotomy for the relief of intention tremor in multiple sclerosis. Acta Neurol Scand 38(Suppl 3):153&#x2013;156 </citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carpenter</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Anatomic degenerations and physiologic effects resulting from localized lesions of the red nucleus</article-title>
          <source>J Comp Neurol</source>
          <year>1956</year>
          <volume>105</volume>
          <fpage>195</fpage>
          <lpage>239</lpage>
        </citation>
        <citation citation-type="display-unstructured">Carpenter MB (1956) Anatomic degenerations and physiologic effects resulting from localized lesions of the red nucleus. J Comp Neurol 105:195&#x2013;239 <pub-id pub-id-type="pmid">13385374</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carpenter</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Effects of thalamic lesions upon cerebellar dyskinesia in the rhesus monkey</article-title>
          <source>J Comp Neurol</source>
          <year>1962</year>
          <volume>119</volume>
          <fpage>127</fpage>
          <lpage>147</lpage>
        </citation>
        <citation citation-type="display-unstructured">Carpenter MB, Hanna GR (1962) Effects of thalamic lesions upon cerebellar dyskinesia in the rhesus monkey. J Comp Neurol 119:127&#x2013;147 <pub-id pub-id-type="pmid">14018825</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clifford</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Tetrahydrocannabinol for tremor in multiple sclerosis</article-title>
          <source>Ann Neurol</source>
          <year>1983</year>
          <volume>13</volume>
          <fpage>669</fpage>
          <lpage>671</lpage>
        </citation>
        <citation citation-type="display-unstructured">Clifford DB (1983) Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol 13:669&#x2013;671 <pub-id pub-id-type="pmid">6309074</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conrad</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>VB</given-names>
            </name>
          </person-group>
          <article-title>Cerebellare Bewegungsst&#xF6;rungen im Tierversuch. Vergleich rascher Alternativbewegungen und langsamerer Zielbewegungen w&#xE4;hrend reversibler Dentatusausschaltung</article-title>
          <source>J Neurol</source>
          <year>1975</year>
          <volume>209</volume>
          <fpage>165</fpage>
          <lpage>179</lpage>
        </citation>
        <citation citation-type="display-unstructured">Conrad B, Brooks VB (1975) Cerebellare Bewegungsst&#xF6;rungen im Tierversuch. Vergleich rascher Alternativbewegungen und langsamerer Zielbewegungen w&#xE4;hrend reversibler Dentatusausschaltung. J Neurol 209:165&#x2013;179 <pub-id pub-id-type="pmid">51058</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Consroe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Musty</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tillery</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Pertwee</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The perceived effects of smoked cannabis on patients with multiple sclerosis</article-title>
          <source>Eur Neurol</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>44</fpage>
          <lpage>48</lpage>
        </citation>
        <citation citation-type="display-unstructured">Consroe P, Musty R, Rein J, Tillery W, Pertwee R (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 38:44&#x2013;48 <pub-id pub-id-type="pmid">9252798</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooper</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Neurosurgical alleviation of intention tremor of multiple sclerosis and cerebellar disease</article-title>
          <source>N Engl J Med</source>
          <year>1960</year>
          <volume>263</volume>
          <fpage>441</fpage>
          <lpage>444</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cooper IS (1960) Neurosurgical alleviation of intention tremor of multiple sclerosis and cerebellar disease. N Engl J Med 263:441&#x2013;444 <pub-id pub-id-type="pmid">13811793</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooper</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Neurosurgical relief of intention tremor due to cerebellar disease and multiple sclerosis</article-title>
          <source>Arch Phys Med Rehabil</source>
          <year>1960</year>
          <volume>41</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cooper IS (1960) Neurosurgical relief of intention tremor due to cerebellar disease and multiple sclerosis. Arch Phys Med Rehabil 41:1&#x2013;4 <pub-id pub-id-type="pmid">13811794</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooper</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Relief of intention tremor of multiple sclerosis by thalamic surgery</article-title>
          <source>JAMA</source>
          <year>1967</year>
          <volume>199</volume>
          <fpage>689</fpage>
          <lpage>694</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cooper IS (1967) Relief of intention tremor of multiple sclerosis by thalamic surgery. JAMA 199:689&#x2013;694 <pub-id pub-id-type="pmid">6071332</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Critchley</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Vim thalamotomy for the relief of the intention tremor of multiple sclerosis</article-title>
          <source>Br J Neurosurg</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>559</fpage>
          <lpage>562</lpage>
        </citation>
        <citation citation-type="display-unstructured">Critchley GR, Richardson PL (1998) Vim thalamotomy for the relief of the intention tremor of multiple sclerosis. Br J Neurosurg 12:559&#x2013;562 <pub-id pub-id-type="pmid">10070467</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dahlin-Webb</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>A weighted wrist cuff</article-title>
          <source>Am J Occup Ther</source>
          <year>1986</year>
          <volume>40</volume>
          <fpage>363</fpage>
          <lpage>364</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dahlin-Webb SR (1986) A weighted wrist cuff. Am J Occup Ther 40:363&#x2013;364 <pub-id pub-id-type="pmid">3717271</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deuschl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Consensus statement of the Movement Disorder Society on Tremor</article-title>
          <source>Ad Hoc Scientific Committee. Mov Disord</source>
          <year>1998</year>
          <volume>13</volume>
          <issue>Suppl 3</issue>
          <fpage>2</fpage>
          <lpage>23</lpage>
        </citation>
        <citation citation-type="display-unstructured">Deuschl G, Bain P, Brin M (1998) Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 13(Suppl 3):2&#x2013;23 </citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deuschl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Raethjen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lindemann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Krack</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The pathophysiology of tremor</article-title>
          <source>Muscle Nerve</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>716</fpage>
          <lpage>735</lpage>
        </citation>
        <citation citation-type="display-unstructured">Deuschl G, Raethjen J, Lindemann M, Krack P (2001) The pathophysiology of tremor. Muscle Nerve 24:716&#x2013;735 <pub-id pub-id-type="pmid">11360255</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="other">Dow RS, Moruzzi G (1958) The Physiology and Pathophysiology of the Cerebellum.</citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duquette</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pleines</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>du</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Isoniazid for tremor in multiple sclerosis: a controlled trial</article-title>
          <source>Neurology</source>
          <year>1985</year>
          <volume>35</volume>
          <fpage>1772</fpage>
          <lpage>1775</lpage>
        </citation>
        <citation citation-type="display-unstructured">Duquette P, Pleines J, du SP (1985) Isoniazid for tremor in multiple sclerosis: a controlled trial. Neurology 35:1772&#x2013;1775 <pub-id pub-id-type="pmid">3906430</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="other">Fahn S, Tolosa E, Marin C (1988) Clinical rating scale for tremor. 225&#x2013;234</citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferraro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barrera</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>The effects of lesions of the superior cerebellar peduncle in the Macacus rhesus monkey</article-title>
          <source>Bull Neur Inst NY</source>
          <year>1936</year>
          <volume>5</volume>
          <fpage>165</fpage>
          <lpage>179</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ferraro A, Barrera SE (1936) The effects of lesions of the superior cerebellar peduncle in the Macacus rhesus monkey. Bull Neur Inst NY 5:165&#x2013;179 </citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feys</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Helsen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Mooren</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Albrecht</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nuttin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ketelaer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Effects of peripheral cooling on intention tremor in multiple sclerosis</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2005</year>
          <volume>76</volume>
          <fpage>373</fpage>
          <lpage>379</lpage>
        </citation>
        <citation citation-type="display-unstructured">Feys P, Helsen W, Liu X, Mooren D, Albrecht H, Nuttin B, Ketelaer P (2005) Effects of peripheral cooling on intention tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 76:373&#x2013;379 <pub-id pub-id-type="pmid">15716530</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feys</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Romberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ruutiainen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Davies-Smith</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Avizzano</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bergamasco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ketelaer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Assistive technology to improve PC interaction for people with intention tremor</article-title>
          <source>J Rehabil Res Dev</source>
          <year>2001</year>
          <volume>38</volume>
          <fpage>235</fpage>
          <lpage>243</lpage>
        </citation>
        <citation citation-type="display-unstructured">Feys P, Romberg A, Ruutiainen J, Davies-Smith A, Jones R, Avizzano CA, Bergamasco M, Ketelaer P (2001) Assistive technology to improve PC interaction for people with intention tremor. J Rehabil Res Dev 38:235&#x2013;243 <pub-id pub-id-type="pmid">11392656</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fox</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Glickman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zajicek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The effect of cannabis on tremor in patients with multiple sclerosis</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>62</volume>
          <fpage>1105</fpage>
          <lpage>1109</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fox P, Bain PG, Glickman S, Carroll C, Zajicek J (2004) The effect of cannabis on tremor in patients with multiple sclerosis. Neurology 62:1105&#x2013;1109 <pub-id pub-id-type="pmid">15079008</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Grundy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Heron</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1986</year>
          <volume>49</volume>
          <fpage>87</fpage>
          <lpage>89</lpage>
        </citation>
        <citation citation-type="display-unstructured">Francis DA, Grundy D, Heron JR (1986) The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry. J Neurol Neurosurg Psychiatry 49:87&#x2013;89 <pub-id pub-id-type="pmid">3958735</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gbadamosi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buhmann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moench</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heesen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Failure of ondansetron in treating cerebellar tremor in MS patients-an open-label pilot study</article-title>
          <source>Acta Neurol Scand</source>
          <year>2001</year>
          <volume>104</volume>
          <fpage>308</fpage>
          <lpage>311</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gbadamosi J, Buhmann C, Moench A, Heesen C (2001) Failure of ondansetron in treating cerebellar tremor in MS patients-an open-label pilot study. Acta Neurol Scand 104:308&#x2013;311 <pub-id pub-id-type="pmid">11696026</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gemba</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yoneda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Tremor in the monkey with a cerebellar lesion</article-title>
          <source>Exp Neurol</source>
          <year>1980</year>
          <volume>69</volume>
          <fpage>173</fpage>
          <lpage>182</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gemba H, Sasaki K, Yoneda Y, Hashimoto S, Mizuno N (1980) Tremor in the monkey with a cerebellar lesion. Exp Neurol 69:173&#x2013;182 <pub-id pub-id-type="pmid">6771153</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geny</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Pollin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Feve</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ricolfi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cesaro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Degos</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation</article-title>
          <source>Mov Disord</source>
          <year>1996</year>
          <volume>11</volume>
          <fpage>489</fpage>
          <lpage>494</lpage>
        </citation>
        <citation citation-type="display-unstructured">Geny C, Nguyen JP, Pollin B, Feve A, Ricolfi F, Cesaro P, Degos JD (1996) Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord 11:489&#x2013;494 <pub-id pub-id-type="pmid">8866489</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carr</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hollenberg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Kinematic effects of deafferentation and cerebellar ablation</article-title>
          <source>Brain</source>
          <year>1976</year>
          <volume>99</volume>
          <fpage>311</fpage>
          <lpage>330</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gilman S, Carr D, Hollenberg J (1976) Kinematic effects of deafferentation and cerebellar ablation. Brain 99:311&#x2013;330 <pub-id pub-id-type="pmid">825186</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldman</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor</article-title>
          <source>J Neurosurg</source>
          <year>1992</year>
          <volume>77</volume>
          <fpage>223</fpage>
          <lpage>229</lpage>
        </citation>
        <citation citation-type="display-unstructured">Goldman MS, Kelly PJ (1992) Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor. J Neurosurg 77:223&#x2013;229 <pub-id pub-id-type="pmid">1625009</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hallett</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lindsey</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Adelstein</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>PO</given-names>
            </name>
          </person-group>
          <article-title>Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis</article-title>
          <source>Neurology</source>
          <year>1985</year>
          <volume>35</volume>
          <fpage>1374</fpage>
          <lpage>1377</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hallett M, Lindsey JW, Adelstein BD, Riley PO (1985) Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis. Neurology 35:1374&#x2013;1377 <pub-id pub-id-type="pmid">3895037</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hauptvogel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Poser</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Orthner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Roeder</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Indikationen zur stereotaktischen Operation bei Patienten mit Multipler Sklerose</article-title>
          <source>J Neurol</source>
          <year>1975</year>
          <volume>210</volume>
          <fpage>239</fpage>
          <lpage>251</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hauptvogel H, Poser S, Orthner H, Roeder F (1975) Indikationen zur stereotaktischen Operation bei Patienten mit Multipler Sklerose. J Neurol 210:239&#x2013;251 <pub-id pub-id-type="pmid">52694</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hay</surname>
              <given-names>OD</given-names>
            </name>
          </person-group>
          <article-title>Thalamic deep brain stimulation for treatment of visual symptoms in multiple sclerosis</article-title>
          <source>Clinical Eye and Vision Care</source>
          <year>1999</year>
          <volume>11</volume>
          <fpage>121</fpage>
          <lpage>131</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hay OD (1999) Thalamic deep brain stimulation for treatment of visual symptoms in multiple sclerosis. Clinical Eye and Vision Care 11:121&#x2013;131 </citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henkin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Herishanu</surname>
              <given-names>YO</given-names>
            </name>
          </person-group>
          <article-title>Primidone as a treatment for cerebellar tremor in multiple sclerosis&#x2013;two case reports</article-title>
          <source>Isr J Med Sci</source>
          <year>1989</year>
          <volume>25</volume>
          <fpage>720</fpage>
          <lpage>721</lpage>
        </citation>
        <citation citation-type="display-unstructured">Henkin Y, Herishanu YO (1989) Primidone as a treatment for cerebellar tremor in multiple sclerosis&#x2013;two case reports. Isr J Med Sci 25:720&#x2013;721 <pub-id pub-id-type="pmid">2613506</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hitchcock</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Flint</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Gutowski</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Thalamotomy for movement disorders: a critical appraisal</article-title>
          <source>Acta Neurochir Suppl (Wien)</source>
          <year>1987</year>
          <volume>39</volume>
          <fpage>61</fpage>
          <lpage>65</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hitchcock E, Flint GA, Gutowski NJ (1987) Thalamotomy for movement disorders: a critical appraisal. Acta Neurochir Suppl (Wien) 39:61&#x2013;65 <pub-id pub-id-type="pmid">3478985</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hooper</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pentland</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Whittle</surname>
              <given-names>IR</given-names>
            </name>
          </person-group>
          <article-title>A prospective study of thalamic deep brain stimulation for the treatment of movement disorders in multiple sclerosis</article-title>
          <source>Br J Neurosurg</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>102</fpage>
          <lpage>109</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hooper J, Taylor R, Pentland B, Whittle IR (2002) A prospective study of thalamic deep brain stimulation for the treatment of movement disorders in multiple sclerosis. Br J Neurosurg 16:102&#x2013;109 <pub-id pub-id-type="pmid">12046727</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hooper</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Whittle</surname>
              <given-names>IR</given-names>
            </name>
          </person-group>
          <article-title>Long-term outcome after thalamotomy for movement disorders in multiple sclerosis</article-title>
          <source>Lancet</source>
          <year>1998</year>
          <volume>352</volume>
          <fpage>1984</fpage>
        </citation>
        <citation citation-type="display-unstructured">Hooper J, Whittle IR (1998) Long-term outcome after thalamotomy for movement disorders in multiple sclerosis. Lancet 352:1984 <pub-id pub-id-type="pmid">9872251</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kandel</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Hondcarian</surname>
              <given-names>OA</given-names>
            </name>
          </person-group>
          <article-title>Surgical treatment of the hyperkinetic form of multiple sclerosis</article-title>
          <source>Acta Neurol (Napoli)</source>
          <year>1985</year>
          <volume>7</volume>
          <fpage>345</fpage>
          <lpage>347</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kandel EI, Hondcarian OA (1985) Surgical treatment of the hyperkinetic form of multiple sclerosis. Acta Neurol (Napoli) 7:345&#x2013;347 <pub-id pub-id-type="pmid">4061145</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koller</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Pharmacologic trials in the treatment of cerebellar tremor</article-title>
          <source>Arch Neurol</source>
          <year>1984</year>
          <volume>41</volume>
          <fpage>280</fpage>
          <lpage>281</lpage>
        </citation>
        <citation citation-type="display-unstructured">Koller WC (1984) Pharmacologic trials in the treatment of cerebellar tremor. Arch Neurol 41:280&#x2013;281 <pub-id pub-id-type="pmid">6365047</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krauss</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Ondo</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Pohle</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Burgunder</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Jankovic</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application</article-title>
          <source>Neurosurgery</source>
          <year>2001</year>
          <volume>48</volume>
          <fpage>535</fpage>
          <lpage>541</lpage>
        </citation>
        <citation citation-type="display-unstructured">Krauss JK, Simpson RK, Jr, Ondo WG, Pohle T, Burgunder JM, Jankovic J (2001) Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery 48:535&#x2013;541 <pub-id pub-id-type="pmid">11270543</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krayenbuhl</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yasargil</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Relief of Intention Tremor Due to Multiple Sclerosis by Stereotaxic Thalamotomy</article-title>
          <source>Confinia Neurologica</source>
          <year>1962</year>
          <volume>22</volume>
          <fpage>368</fpage>
        </citation>
        <citation citation-type="display-unstructured">Krayenbuhl H, Yasargil MG (1962) Relief of Intention Tremor Due to Multiple Sclerosis by Stereotaxic Thalamotomy. Confinia Neurologica 22:368 <pub-id pub-id-type="pmid">14035616</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurtzke</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>A new scale for evaluating disability in multiple sclerosis</article-title>
          <source>Neurology</source>
          <year>1955</year>
          <volume>5</volume>
          <fpage>580</fpage>
          <lpage>583</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kurtzke JF (1955) A new scale for evaluating disability in multiple sclerosis. Neurology 5:580&#x2013;583 <pub-id pub-id-type="pmid">13244774</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>DeLisa</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bach</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>The effect of temperature on antidromic median sensory conduction</article-title>
          <source>Electromyogr Clin Neurophysiol</source>
          <year>1993</year>
          <volume>33</volume>
          <fpage>125</fpage>
          <lpage>128</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lee HJ, DeLisa JA, Bach JR (1993) The effect of temperature on antidromic median sensory conduction. Electromyogr Clin Neurophysiol 33:125&#x2013;128 <pub-id pub-id-type="pmid">8449169</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lenz</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Dostrovsky</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Tasker</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Yamashiro</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Single-unit analysis of the human ventral thalamic nuclear group: somatosensory responses</article-title>
          <source>J Neurophysiol</source>
          <year>1988</year>
          <volume>59</volume>
          <fpage>299</fpage>
          <lpage>316</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lenz FA, Dostrovsky JO, Tasker RR, Yamashiro K, Kwan HC, Murphy JT (1988) Single-unit analysis of the human ventral thalamic nuclear group: somatosensory responses. J Neurophysiol 59:299&#x2013;316 <pub-id pub-id-type="pmid">3351564</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lenz</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Normand</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rowland</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Seike</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Tasker</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Dostrovsky</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
          <article-title>Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor</article-title>
          <source>Mov Disord</source>
          <year>1995</year>
          <volume>10</volume>
          <fpage>318</fpage>
          <lpage>328</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lenz FA, Normand SL, Kwan HC, Andrews D, Rowland LH, Jones MW, Seike M, Lin YC, Tasker RR, Dostrovsky JO (1995) Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor. Mov Disord 10:318&#x2013;328 <pub-id pub-id-type="pmid">7651450</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lenz</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Tasker</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Schider</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kwong</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dostrovsky</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Selection of the optimal lesion site for the relief of parkinsonian tremor on the basis of spectral analysis of neuronal firing patterns</article-title>
          <source>Appl Neurophysiol</source>
          <year>1987</year>
          <volume>50</volume>
          <fpage>338</fpage>
          <lpage>343</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lenz FA, Tasker RR, Kwan HC, Schider S, Kwong R, Dostrovsky JO, Murphy JT (1987) Selection of the optimal lesion site for the relief of parkinsonian tremor on the basis of spectral analysis of neuronal firing patterns. Appl Neurophysiol 50:338&#x2013;343 <pub-id pub-id-type="pmid">3329872</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>TZ</given-names>
            </name>
            <name>
              <surname>Miall</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Alusi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Frequency analysis of involuntary movements during wrist tracking: a way to identify ms patients with tremor who benefit from thalamotomy</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>2000</year>
          <volume>74</volume>
          <fpage>53</fpage>
          <lpage>62</lpage>
        </citation>
        <citation citation-type="display-unstructured">Liu X, Aziz TZ, Miall RC, Rowe J, Alusi SH, Bain PG, Stein JF (2000) Frequency analysis of involuntary movements during wrist tracking: a way to identify ms patients with tremor who benefit from thalamotomy. Stereotact Funct Neurosurg 74:53&#x2013;62 <pub-id pub-id-type="pmid">11251395</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loher</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Gutbrod</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fravi</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Pohle</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Burgunder</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Krauss</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect</article-title>
          <source>J Neurol</source>
          <year>2003</year>
          <volume>250</volume>
          <fpage>707</fpage>
          <lpage>713</lpage>
        </citation>
        <citation citation-type="display-unstructured">Loher TJ, Gutbrod K, Fravi NL, Pohle T, Burgunder JM, Krauss JK (2003) Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect. J Neurol 250:707&#x2013;713 <pub-id pub-id-type="pmid">12796834</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ahlskog</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sneve</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Noseworthy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>1876</fpage>
          <lpage>1882</lpage>
        </citation>
        <citation citation-type="display-unstructured">Matsumoto J, Morrow D, Kaufman K, Davis D, Ahlskog JE, Walker A, Sneve D, Noseworthy J, Rodriguez M (2001) Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology 57:1876&#x2013;1882 <pub-id pub-id-type="pmid">11723279</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meinck</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Schonle</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Conrad</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Effect of cannabinoids on spasticity and ataxia in multiple sclerosis</article-title>
          <source>J Neurol</source>
          <year>1989</year>
          <volume>236</volume>
          <fpage>120</fpage>
          <lpage>122</lpage>
        </citation>
        <citation citation-type="display-unstructured">Meinck HM, Schonle PW, Conrad B (1989) Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 236:120&#x2013;122 <pub-id pub-id-type="pmid">2709054</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mense</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effects of temperature on the discharges of muscle spindles and tendon organs</article-title>
          <source>Pflugers Arch</source>
          <year>1978</year>
          <volume>374</volume>
          <fpage>159</fpage>
          <lpage>166</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mense S (1978) Effects of temperature on the discharges of muscle spindles and tendon organs. Pflugers Arch 374:159&#x2013;166 <pub-id pub-id-type="pmid">566425</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monaca-Charley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stojkovic</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Duhamel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seze</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ferriby</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vermersch</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis</article-title>
          <source>J Neurol</source>
          <year>2003</year>
          <volume>250</volume>
          <fpage>1190</fpage>
          <lpage>1194</lpage>
        </citation>
        <citation citation-type="display-unstructured">Monaca-Charley C, Stojkovic T, Duhamel A, De Seze J, Ferriby D, Vermersch P (2003) Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis. J Neurol 250:1190&#x2013;1194 <pub-id pub-id-type="pmid">14586600</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montgomery</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Kinkel</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Barnett</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Chronic thalamic stimulation for the tremor of multiple sclerosis</article-title>
          <source>Neurology</source>
          <year>1999</year>
          <volume>53</volume>
          <fpage>625</fpage>
          <lpage>628</lpage>
        </citation>
        <citation citation-type="display-unstructured">Montgomery EB, Jr, Baker KB, Kinkel RP, Barnett G (1999) Chronic thalamic stimulation for the tremor of multiple sclerosis. Neurology 53:625&#x2013;628 <pub-id pub-id-type="pmid">10449132</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morrow</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McDowell</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ritchie</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Patterson</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Isoniazid and action tremor in multiple sclerosis</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1985</year>
          <volume>48</volume>
          <fpage>282</fpage>
          <lpage>283</lpage>
        </citation>
        <citation citation-type="display-unstructured">Morrow J, McDowell H, Ritchie C, Patterson V (1985) Isoniazid and action tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 48:282&#x2013;283 <pub-id pub-id-type="pmid">3981201</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mundinger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Postoperative and long-term results after stereotactic operations for action myoclonia in cases of encephalomyelitis disseminata</article-title>
          <source>Appl Neurophysiol</source>
          <year>1982</year>
          <volume>45</volume>
          <fpage>299</fpage>
          <lpage>305</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mundinger F, Kuhn I (1982) Postoperative and long-term results after stereotactic operations for action myoclonia in cases of encephalomyelitis disseminata. Appl Neurophysiol 45:299&#x2013;305 <pub-id pub-id-type="pmid">7036860</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nandi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>TZ</given-names>
            </name>
          </person-group>
          <article-title>Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor</article-title>
          <source>J Clin Neurophysiol</source>
          <year>2004</year>
          <volume>21</volume>
          <fpage>31</fpage>
          <lpage>39</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nandi D, Aziz TZ (2004) Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor. J Clin Neurophysiol 21:31&#x2013;39 <pub-id pub-id-type="pmid">15097292</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nandi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chir</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Parkin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Joint</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gregory</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological confirmation of the zona incerta as a target for surgical treatment of disabling involuntary arm movements in multiple sclerosis: use of local field potentials</article-title>
          <source>J Clin Neurosci</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>64</fpage>
          <lpage>68</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nandi D, Chir M, Liu X, Bain P, Parkin S, Joint C, Winter J, Stein J, Scott R, Gregory R, Aziz T (2002) Electrophysiological confirmation of the zona incerta as a target for surgical treatment of disabling involuntary arm movements in multiple sclerosis: use of local field potentials. J Clin Neurosci 9:64&#x2013;68 <pub-id pub-id-type="pmid">11749021</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nguyen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Degos</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Thalamic stimulation and proximal tremor. A specific target in the nucleus ventrointermedius thalami</article-title>
          <source>Arch Neurol</source>
          <year>1993</year>
          <volume>50</volume>
          <fpage>498</fpage>
          <lpage>500</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nguyen JP, Degos JD (1993) Thalamic stimulation and proximal tremor. A specific target in the nucleus ventrointermedius thalami. Arch Neurol 50:498&#x2013;500 <pub-id pub-id-type="pmid">8489406</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niranjan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kondziolka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Baser</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heyman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lunsford</surname>
              <given-names>LD</given-names>
            </name>
          </person-group>
          <article-title>Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>443</fpage>
          <lpage>446</lpage>
        </citation>
        <citation citation-type="display-unstructured">Niranjan A, Kondziolka D, Baser S, Heyman R, Lunsford LD (2000) Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor. Neurology 55:443&#x2013;446 <pub-id pub-id-type="pmid">10932286</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohye</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Use of selective thalamotomy for various kinds of movement disorder, based on basic studies</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>54</fpage>
          <lpage>65</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ohye C (2000) Use of selective thalamotomy for various kinds of movement disorder, based on basic studies. Stereotact Funct Neurosurg 75:54&#x2013;65 <pub-id pub-id-type="pmid">11740171</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pittock</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>McClelland</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Mayr</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>JY</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population</article-title>
          <source>Mov Disord</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>1482</fpage>
          <lpage>1485</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY (2004) Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord 19:1482&#x2013;1485 <pub-id pub-id-type="pmid">15390075</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poirier</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Lafleur</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lean</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guiot</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Larochelle</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Physiopathology of the cerebellum in the monkey. 2. Motor disturbances associated with partial and complete destruction of cerebellar structures</article-title>
          <source>J Neurol Sci</source>
          <year>1974</year>
          <volume>22</volume>
          <fpage>491</fpage>
          <lpage>509</lpage>
        </citation>
        <citation citation-type="display-unstructured">Poirier LJ, Lafleur J, de Lean J, Guiot G, Larochelle L, Boucher R (1974) Physiopathology of the cerebellum in the monkey. 2. Motor disturbances associated with partial and complete destruction of cerebellar structures. J Neurol Sci 22:491&#x2013;509 <pub-id pub-id-type="pmid">4211163</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poirier</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Lafleur</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lean</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guiot</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Larochelle</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Physiopathology of the cerebellum in the monkey. 2. Motor disturbances associated with partial and complete destruction of cerebellar structures</article-title>
          <source>J Neurol Sci</source>
          <year>1974</year>
          <volume>22</volume>
          <fpage>491</fpage>
          <lpage>509</lpage>
        </citation>
        <citation citation-type="display-unstructured">Poirier LJ, Lafleur J, de Lean J, Guiot G, Larochelle L, Boucher R (1974) Physiopathology of the cerebellum in the monkey. 2. Motor disturbances associated with partial and complete destruction of cerebellar structures. J Neurol Sci 22:491&#x2013;509 <pub-id pub-id-type="pmid">4211163</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quintern</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Immisch</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Albrecht</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pollmann</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Glasauer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Straube</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Influence of visual and proprioceptive afferences on upper limb ataxia in patients with multiple sclerosis</article-title>
          <source>J Neurol Sci</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>61</fpage>
          <lpage>69</lpage>
        </citation>
        <citation citation-type="display-unstructured">Quintern J, Immisch I, Albrecht H, Pollmann W, Glasauer S, Straube A (1999) Influence of visual and proprioceptive afferences on upper limb ataxia in patients with multiple sclerosis. J Neurol Sci 163:61&#x2013;69 <pub-id pub-id-type="pmid">10223413</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rice</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Lesaux</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vandervoort</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Macewan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ebers</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1997</year>
          <volume>62</volume>
          <fpage>282</fpage>
          <lpage>284</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rice GP, Lesaux J, Vandervoort P, Macewan L, Ebers GC (1997) Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor. J Neurol Neurosurg Psychiatry 62:282&#x2013;284 <pub-id pub-id-type="pmid">9069487</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riechert</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Stereotaktische Operationen zur Behandlung des Tremors der Multiplen Sklerose</article-title>
          <source>Schweiz Arch Neurol Neurochir Psychiatr</source>
          <year>1972</year>
          <volume>111</volume>
          <fpage>411</fpage>
          <lpage>416</lpage>
        </citation>
        <citation citation-type="display-unstructured">Riechert T, Richter D (1972) Stereotaktische Operationen zur Behandlung des Tremors der Multiplen Sklerose. Schweiz Arch Neurol Neurochir Psychiatr 111:411&#x2013;416 <pub-id pub-id-type="pmid">4569347</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sabra</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Hallett</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sudarsky</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mullally</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Treatment of action tremor in multiple sclerosis with isoniazid</article-title>
          <source>Neurology</source>
          <year>1982</year>
          <volume>32</volume>
          <fpage>912</fpage>
          <lpage>913</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sabra AF, Hallett M, Sudarsky L, Mullally W (1982) Treatment of action tremor in multiple sclerosis with isoniazid. Neurology 32:912&#x2013;913 <pub-id pub-id-type="pmid">7201590</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samra</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Waltz</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Riklan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koslow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Relief of intention tremor by thalamic surgery</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1970</year>
          <volume>33</volume>
          <fpage>7</fpage>
          <lpage>15</lpage>
        </citation>
        <citation citation-type="display-unstructured">Samra K, Waltz JM, Riklan M, Koslow M, Cooper IS (1970) Relief of intention tremor by thalamic surgery. J Neurol Neurosurg Psychiatry 33:7&#x2013;15 <pub-id pub-id-type="pmid">5418181</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandyk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dann</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Weak electromagnetic fields attenuate tremor in multiple sclerosis</article-title>
          <source>Int J Neurosci</source>
          <year>1994</year>
          <volume>79</volume>
          <fpage>199</fpage>
          <lpage>212</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sandyk R, Dann LC (1994) Weak electromagnetic fields attenuate tremor in multiple sclerosis. Int J Neurosci 79:199&#x2013;212 <pub-id pub-id-type="pmid">7744562</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sernas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mahalick</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Adler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Thalamic stimulation in patients with multiple sclerosis</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>1999</year>
          <volume>72</volume>
          <fpage>196</fpage>
          <lpage>201</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schulder M, Sernas T, Mahalick D, Adler R, Cook S (1999) Thalamic stimulation in patients with multiple sclerosis. Stereotact Funct Neurosurg 72:196&#x2013;201 <pub-id pub-id-type="pmid">10853078</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sernas</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Karimi</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Thalamic stimulation in patients with multiple sclerosis: long-term follow-up</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>2003</year>
          <volume>80</volume>
          <fpage>48</fpage>
          <lpage>55</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schulder M, Sernas TJ, Karimi R (2003) Thalamic stimulation in patients with multiple sclerosis: long-term follow-up. Stereotact Funct Neurosurg 80:48&#x2013;55 <pub-id pub-id-type="pmid">14745209</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuurman</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Bossuyt</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Bonsel</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Someren</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Bie</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Merkus</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Speelman</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>342</volume>
          <fpage>461</fpage>
          <lpage>468</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342:461&#x2013;468 <pub-id pub-id-type="pmid">10675426</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sechi</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Zuddas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Piredda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agnetti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sau</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Piras</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Tanca</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosati</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up</article-title>
          <source>Neurology</source>
          <year>1989</year>
          <volume>39</volume>
          <fpage>1113</fpage>
          <lpage>1115</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sechi GP, Zuddas M, Piredda M, Agnetti V, Sau G, Piras ML, Tanca S, Rosati G (1989) Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up. Neurology 39:1113&#x2013;1115 <pub-id pub-id-type="pmid">2668787</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shahzadi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tasker</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Lozano</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Thalamotomy for essential and cerebellar tremor</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>1995</year>
          <volume>65</volume>
          <fpage>11</fpage>
          <lpage>17</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shahzadi S, Tasker RR, Lozano A (1995) Thalamotomy for essential and cerebellar tremor. Stereotact Funct Neurosurg 65:11&#x2013;17 <pub-id pub-id-type="pmid">8916323</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siegfried</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lippitz</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of movement disorders: personal experience since 1982</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>1994</year>
          <volume>62</volume>
          <fpage>71</fpage>
          <lpage>75</lpage>
        </citation>
        <citation citation-type="display-unstructured">Siegfried J, Lippitz B (1994) Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of movement disorders: personal experience since 1982. Stereotact Funct Neurosurg 62:71&#x2013;75 <pub-id pub-id-type="pmid">7631091</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Speelman</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Manen</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Stereotactic thalamotomy for the relief of intention tremor of multiple sclerosis</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1984</year>
          <volume>47</volume>
          <fpage>596</fpage>
          <lpage>599</lpage>
        </citation>
        <citation citation-type="display-unstructured">Speelman JD, Van Manen J (1984) Stereotactic thalamotomy for the relief of intention tremor of multiple sclerosis. J Neurol Neurosurg Psychiatry 47:596&#x2013;599 <pub-id pub-id-type="pmid">6376713</pub-id></citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taha</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Janszen</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Favre</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor</article-title>
          <source>J Neurosurg</source>
          <year>1999</year>
          <volume>91</volume>
          <fpage>68</fpage>
          <lpage>72</lpage>
        </citation>
        <citation citation-type="display-unstructured">Taha JM, Janszen MA, Favre J (1999) Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg 91:68&#x2013;72 <pub-id pub-id-type="pmid">10389882</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manen</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Stereotaxic operations in cases of hereditary and intention tremor</article-title>
          <source>Acta Neurochir (Wien) Suppl</source>
          <year>1974</year>
          <volume>21</volume>
          <fpage>49</fpage>
          <lpage>55</lpage>
        </citation>
        <citation citation-type="display-unstructured">Van Manen J (1974) Stereotaxic operations in cases of hereditary and intention tremor. Acta Neurochir (Wien) Suppl 21:49&#x2013;55 </citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wade</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Makela</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>House</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bateman</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients</article-title>
          <source>Mult Scler</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>434</fpage>
          <lpage>441</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wade DT, Makela P, Robson P, House H, Bateman C (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 10:434&#x2013;441 <pub-id pub-id-type="pmid">15327042</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Botterell</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>The syndrome of the superior cerebellar peduncle in the monkey</article-title>
          <source>Brain</source>
          <year>1937</year>
          <volume>60</volume>
          <fpage>327</fpage>
          <lpage>341</lpage>
        </citation>
        <citation citation-type="display-unstructured">Walker AE, Botterell EH (1937) The syndrome of the superior cerebellar peduncle in the monkey. Brain 60:327&#x2013;341 </citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinshenker</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Issa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baskerville</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study</article-title>
          <source>Arch Neurol</source>
          <year>1996</year>
          <volume>53</volume>
          <fpage>353</fpage>
          <lpage>358</lpage>
        </citation>
        <citation citation-type="display-unstructured">Weinshenker BG, Issa M, Baskerville J (1996) Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study. Arch Neurol 53:353&#x2013;358 <pub-id pub-id-type="pmid">8929158</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinshenker</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Noseworthy</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Carriere</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Baskerville</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ebers</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome</article-title>
          <source>Brain</source>
          <year>1991</year>
          <volume>114</volume>
          <fpage>1045</fpage>
          <lpage>1056</lpage>
        </citation>
        <citation citation-type="display-unstructured">Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1991) The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114:1045&#x2013;1056 <pub-id pub-id-type="pmid">2043940</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>North</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lenz</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways</article-title>
          <source>Case report. J Neurosurg</source>
          <year>2003</year>
          <volume>99</volume>
          <fpage>768</fpage>
          <lpage>771</lpage>
        </citation>
        <citation citation-type="display-unstructured">Weiss N, North RB, Ohara S, Lenz FA (2003) Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report. J Neurosurg 99:768&#x2013;771 </citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wester</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hauglie-Hanssen</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Stereotaxic thalamotomy&#x2013;experiences from the levodopa era</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1990</year>
          <volume>53</volume>
          <fpage>427</fpage>
          <lpage>430</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wester K, Hauglie-Hanssen E (1990) Stereotaxic thalamotomy&#x2013;experiences from the levodopa era. J Neurol Neurosurg Psychiatry 53:427&#x2013;430 <pub-id pub-id-type="pmid">2191085</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whittle</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Haddow</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>CT guided thalamotomy for movement disorders in multiple sclerosis: problems and paradoxes</article-title>
          <source>Acta Neurochir Suppl (Wien)</source>
          <year>1995</year>
          <volume>64</volume>
          <fpage>13</fpage>
          <lpage>16</lpage>
        </citation>
        <citation citation-type="display-unstructured">Whittle IR, Haddow LJ (1995) CT guided thalamotomy for movement disorders in multiple sclerosis: problems and paradoxes. Acta Neurochir Suppl (Wien) 64:13&#x2013;16 </citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whittle</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pentland</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Thalamic deep-brain stimulation for movement disorders due to multiple sclerosis</article-title>
          <source>Lancet</source>
          <year>1998</year>
          <volume>351</volume>
          <fpage>109</fpage>
          <lpage>110</lpage>
        </citation>
        <citation citation-type="display-unstructured">Whittle IR, Hooper J, Pentland B (1998) Thalamic deep-brain stimulation for movement disorders due to multiple sclerosis. Lancet 351:109&#x2013;110 <pub-id pub-id-type="pmid">9439498</pub-id></citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whittle</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Yau</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Mesodiencephalic targeting of stimulating electrodes in patients with tremor caused by multiple sclerosis</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2004</year>
          <volume>75</volume>
          <fpage>1210</fpage>
        </citation>
        <citation citation-type="display-unstructured">Whittle IR, Yau YH, Hooper J (2004) Mesodiencephalic targeting of stimulating electrodes in patients with tremor caused by multiple sclerosis. J Neurol Neurosurg Psychiatry 75:1210 <pub-id pub-id-type="pmid">15258244</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilms</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sievers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Deuschl</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Animal models of tremor</article-title>
          <source>Mov Disord</source>
          <year>1999</year>
          <volume>14</volume>
          <fpage>557</fpage>
          <lpage>571</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wilms H, Sievers J, Deuschl G (1999) Animal models of tremor. Mov Disord 14:557&#x2013;571 <pub-id pub-id-type="pmid">10435492</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wishart</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Coffey</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>amourian</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Hartley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Flashman</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Fadul</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Saykin</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2003</year>
          <volume>74</volume>
          <fpage>1392</fpage>
          <lpage>1397</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wishart HA, Roberts DW, Roth RM, McDonald BC, Coffey DJ, amourian AC, Hartley C, Flashman LA, Fadul CE, Saykin AJ (2003) Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports. J Neurol Neurosurg Psychiatry 74:1392&#x2013;1397 <pub-id pub-id-type="pmid">14570832</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zajicek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vickery</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nunn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial</article-title>
          <source>Lancet</source>
          <year>2003</year>
          <volume>362</volume>
          <fpage>1517</fpage>
          <lpage>1526</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362:1517&#x2013;1526 <pub-id pub-id-type="pmid">14615106</pub-id></citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>Received in revised form: 2 May 2006</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>